<body>
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government">
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true" class="usa-banner__header-flag" src="/static/img/us_flag.svg" alt="">
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button type="button" class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           " aria-expanded="false" aria-controls="gov-banner-default" data-testid="storybook-django-banner">
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content" id="gov-banner-default" hidden="">
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img" src="/static/img/icon-dot-gov.svg" alt="" aria-hidden="true">
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br>
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img" src="/static/img/icon-https.svg" alt="" aria-hidden="true">

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br>
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg" width="52" height="64" viewBox="0 0 52 64" class="usa-banner__lock-image" role="graphics-symbol" aria-labelledby="banner-lock-description" focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000" fill-rule="evenodd" d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z"></path>
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header="" data-testid="header">
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page" class="ncbi-header__logo-image" src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" width="410" height="100">
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button type="button" class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           " aria-label="Show menu" data-testid="navMenuButton">
    
        

        
                <svg aria-hidden="true" class="ncbi-hamburger-icon" fill="none" focusable="false" height="21" viewBox="0 0 31 21" width="31" xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd" d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z" fill="#F1F1F1" fill-rule="evenodd"></path>
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button type="button" class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           " aria-expanded="false" aria-controls="search-field-desktop-navigation" aria-label="Show search overlay" data-testid="toggleSearchPanelButton" data-toggle-search-panel-button="" data-ga-category="header" data-ga-action="NCBI" data-ga-label="header_search_open">
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true">
        
        <use xlink:href="/static/img/sprite.svg#search"></use>
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button type="button" class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           " aria-expanded="false" aria-controls="login-dropdown-menu" aria-label="Show login menu" data-testid="toggleLoginMenuDropdown" data-desktop-login-button="">
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true">
        
        <use xlink:href="/static/img/sprite.svg#person"></use>
    </svg>



                                <span data-login-dropdown-text="">Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow="">
        
        <use xlink:href="/static/img/sprite.svg#expand_less"></use>
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow="">
        
        <use xlink:href="/static/img/sprite.svg#expand_more"></use>
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu" id="login-dropdown-menu" data-desktop-login-menu-dropdown="" hidden="">
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  ">
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  ">
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  ">
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button type="button" class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           " data-testid="desktopLogoutButton" data-desktop-logout-button="">
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop" data-header-search-panel="" hidden="">
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/" autocomplete="off" class="usa-search usa-search--big ncbi-search-panel__form" data-testid="desktop-navigation-search-form" method="GET" role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input" id="search-field-desktop-navigation" name="term" placeholder="Search NCBI" type="search" value="">
                    



















    
        <button type="submit" class="usa-button
           

           
               
               
               
               
            

           
           
           
           " data-ga-category="header" data-ga-action="NCBI" data-ga-label="header_search_button">
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button type="button" class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           " aria-label="Close navigation menu" data-testid="navCloseButton">
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close">
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6" action="https://www.ncbi.nlm.nih.gov/search/all/" autocomplete="off" data-testid="mobile-navigation-search-form" method="GET" role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input" id="search-field-mobile-navigation" type="search" placeholder="Search NCBI" name="term">

                



















    
        <button type="submit" class="usa-button
           

           
               
               
               
               
            

           
           
           
           " data-ga-category="header" data-ga-action="NCBI" data-ga-label="header_search_button">
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg==" class="usa-search__submit-icon" alt="Search">
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop" data-mobile-login-menu="" hidden="">
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email" data-mobile-login-email-text=""></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  ">
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  ">
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  ">
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button type="button" class="usa-button ncbi-nav__mobile-login-button ncbi--hide-at-desktop" data-testid="mobileLoginButton" data-mobile-login-button="">Log in</button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button type="button" class="usa-button usa-button--unstyled pmc-header__search__button" aria-label="Open search" data-ga-category="search" data-ga-action="PMC" data-ga-label="pmc_search_panel_mobile">
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search" type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/" aria-controls="autoComplete_list_1" aria-autocomplete="both" role="combobox" aria-owns="autoComplete_list_1" aria-haspopup="true" aria-expanded="false"><ul id="autoComplete_list_1" role="listbox" hidden="" aria-label="Suggestions"></ul>
</span>
<button class="usa-button" type="submit" formaction="https://pmc.ncbi.nlm.nih.gov/search/" data-ga-category="search" data-ga-action="PMC" data-ga-label="PMC_search_button">
<span class="usa-search__submit-text">Search in PMC</span>
<img src="/static/img/usa-icons-bg/search--white.svg" class="usa-search__submit-icon" alt="Search">
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link" data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="7325311">

    

   



<div class="grid-container pmc-actions-bar is-not-intersecting" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button type="button" class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex" aria-label="Open resources" data-extra-class="is-visible-resources" data-ga-category="resources_accordion" data-ga-action="click" data-ga-label="mobile_icon">
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <span class="usa-tooltip"><a href="https://doi.org/10.1002/cpt.1827" class="usa-link display-flex usa-tooltip__trigger" role="button" target="_blank" rel="noreferrer noopener" data-position="bottom" aria-label="View on publisher site" data-ga-category="actions" data-ga-action="click" data-ga-label="publisher_link_mobile" aria-describedby="tooltip-961160" tabindex="0">
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a><span class="usa-tooltip__body" id="tooltip-961160" role="tooltip" aria-hidden="true">View on publisher site</span></span>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <span class="usa-tooltip"><a href="pdf/CPT-108-99.pdf" class="usa-link display-flex usa-tooltip__trigger" role="button" data-position="bottom" aria-label="Download PDF" data-ga-category="actions" data-ga-action="click" data-ga-label="pdf_download_mobile" aria-describedby="tooltip-769443" tabindex="0">
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a><span class="usa-tooltip__body" id="tooltip-769443" role="tooltip" aria-hidden="true">Download PDF</span></span>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <span class="usa-tooltip"><button class="usa-button usa-button--unstyled collections-dialog-trigger collections-button display-flex collections-button-empty usa-tooltip__trigger" data-position="bottom" aria-label="Save article in MyNCBI collections." data-ga-category="actions" data-ga-action="click" data-ga-label="collections_button_mobile" data-collections-open-dialog-enabled="false" data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC7325311%2F%23open-collections-dialog" data-in-collections="false" aria-describedby="tooltip-735382" tabindex="0">
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden="">
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden="">
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button><span class="usa-tooltip__body" id="tooltip-735382" role="tooltip" aria-hidden="true">Add to Collections</span></span>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <span class="usa-tooltip"><button role="button" class="usa-button usa-button--unstyled citation-dialog-trigger display-flex usa-tooltip__trigger" aria-label="Open dialog with citation text in different styles" data-position="bottom" data-ga-category="actions" data-ga-action="open" data-ga-label="cite_mobile" data-all-citations-url="/resources/citations/7325311/" data-citation-style="nlm" data-download-format-link="/resources/citations/7325311/export/" aria-describedby="tooltip-936994" tabindex="0">
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden="">
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button><span class="usa-tooltip__body" id="tooltip-936994" role="tooltip" aria-hidden="true">Cite</span></span>
                    </li>
                    
                    <li class="pmc-permalink display-flex">
                         <span class="usa-tooltip"><button type="button" data-position="bottom" class="usa-button usa-button--unstyled display-flex usa-tooltip__trigger" aria-label="Show article permalink" aria-expanded="false" aria-haspopup="true" data-ga-category="actions" data-ga-action="open" data-ga-label="permalink_mobile" aria-describedby="tooltip-849775" tabindex="0">
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button><span class="usa-tooltip__body" id="tooltip-849775" role="tooltip" aria-hidden="true">Permalink</span></span>
                        

<div class="pmc-permalink__dropdown" hidden="">
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC7325311/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link" aria-expanded="false">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button type="button" class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex" aria-label="Open article navigation" data-extra-class="is-visible-in-page" data-ga-category="actions" data-ga-action="open" data-ga-label="article_nav_mobile">
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main id="main-content" class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0">

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-clpt.png" alt="Clinical Pharmacology and Therapeutics logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Clinical Pharmacology and Therapeutics" title="Link to Clinical Pharmacology and Therapeutics" shape="default" href="https://doi.org/10.1002/cpt.1827" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu" aria-expanded="false">Clin Pharmacol Ther</button></div>. 2020 Apr 8;108(1):99–106. doi: <a href="https://doi.org/10.1002/cpt.1827" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1002/cpt.1827</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Clin%20Pharmacol%20Ther%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Clin%20Pharmacol%20Ther%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Clin%20Pharmacol%20Ther%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Clin%20Pharmacol%20Ther%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Assessment of Placental Disposition of Infliximab and Etanercept in Women With Autoimmune Diseases and in the <em>Ex Vivo</em> Perfused Placenta</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Eliesen%20GAM%22%5BAuthor%5D" class="usa-link" aria-describedby="id1" aria-expanded="false"><span class="name western">Gaby A M Eliesen</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Gaby A M Eliesen</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Pharmacology &amp; Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Eliesen%20GAM%22%5BAuthor%5D" class="usa-link"><span class="name western">Gaby A M Eliesen</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20Drongelen%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id2" aria-expanded="false"><span class="name western">Joris van Drongelen</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Joris van Drongelen</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20Drongelen%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Joris van Drongelen</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20Hove%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id3" aria-expanded="false"><span class="name western">Hedwig van Hove</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Hedwig van Hove</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Pharmacology &amp; Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20Hove%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hedwig van Hove</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kooijman%20NI%22%5BAuthor%5D" class="usa-link" aria-describedby="id4" aria-expanded="false"><span class="name western">Nina I Kooijman</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Nina I Kooijman</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Pharmacology &amp; Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kooijman%20NI%22%5BAuthor%5D" class="usa-link"><span class="name western">Nina I Kooijman</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20den%20Broek%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id5" aria-expanded="false"><span class="name western">Petra van den Broek</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Petra van den Broek</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Pharmacology &amp; Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20den%20Broek%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Petra van den Broek</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22de%20Vries%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id6" aria-expanded="false"><span class="name western">Annick de Vries</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Annick de Vries</span></h3>
<div class="p">
<sup><sup>4</sup></sup>Sanquin Diagnostic Services, Amsterdam, The Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22de%20Vries%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Annick de Vries</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Roeleveld%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id7" aria-expanded="false"><span class="name western">Nel Roeleveld</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Nel Roeleveld</span></h3>
<div class="p">
<sup><sup>3</sup></sup>Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Roeleveld%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nel Roeleveld</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Russel%20FGM%22%5BAuthor%5D" class="usa-link" aria-describedby="id8" aria-expanded="false"><span class="name western">Frans G M Russel</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Frans G M Russel</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Pharmacology &amp; Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Russel%20FGM%22%5BAuthor%5D" class="usa-link"><span class="name western">Frans G M Russel</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Greupink%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id9" aria-expanded="false"><span class="name western">Rick Greupink</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Rick Greupink</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Pharmacology &amp; Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Greupink%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rick Greupink</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="cpt1827-aff-0001">
<sup><sup>1</sup></sup>Department of Pharmacology &amp; Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands</div>
<div id="cpt1827-aff-0002">
<sup><sup>2</sup></sup>Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands</div>
<div id="cpt1827-aff-0003">
<sup><sup>3</sup></sup>Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands</div>
<div id="cpt1827-aff-0004">
<sup><sup>4</sup></sup>Sanquin Diagnostic Services, Amsterdam, The Netherlands</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">
Correspondence: Gaby Eliesen (<span>Gaby.Eliesen@radboudumc.nl</span>)</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2019 Dec 17; Accepted 2020 Feb 25; Issue date 2020 Jul.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2020 The Authors. <em>Clinical Pharmacology &amp; Therapeutics</em> published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics</div>
<p>This is an open access article under the terms of the <a href="http://creativecommons.org/licenses/by-nc/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC7325311&nbsp;&nbsp;PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32153014/" class="usa-link">32153014</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="cpt1827-abs-0001"><h2 data-anchor-id="cpt1827-abs-0001"><a id="cpt1827-abs-0001-anchor" data-anchor-id="cpt1827-abs-0001" class="usa-anchor"></a>Abstract</h2>
<p>Tumor necrosis factor (TNF) inhibitors are increasingly applied during pregnancy without clear knowledge of the impact on placenta and fetus. We assessed placental transfer and exposure to infliximab (<em>n</em>&nbsp;=&nbsp;3) and etanercept (<em>n</em>&nbsp;=&nbsp;3) in women with autoimmune diseases. Furthermore, we perfused healthy term placentas for 6&nbsp;hours with 100&nbsp;µg/mL infliximab (<em>n</em>&nbsp;=&nbsp;4) or etanercept (<em>n</em>&nbsp;=&nbsp;5). In pregnant women, infliximab transferred into cord blood but also entered the placenta (cord‐to‐maternal ratio of 1.6&nbsp;±&nbsp;0.4, placenta‐to‐maternal ratio of 0.3&nbsp;±&nbsp;0.1, <em>n</em>&nbsp;=&nbsp;3). For etanercept, a cord‐to‐maternal ratio of 0.04 and placenta‐to‐maternal ratio of 0.03 was observed in one patient only. In <em>ex vivo</em> placenta perfusions, the extent of placental transfer did not differ between the drugs. Final concentrations in the fetal compartment for infliximab and etanercept were 0.3&nbsp;±&nbsp;0.3 and 0.2&nbsp;±&nbsp;0.2&nbsp;µg/mL, respectively. However, in placental tissue, infliximab levels exceeded those of etanercept (19&nbsp;±&nbsp;6 vs. 1&nbsp;±&nbsp;3&nbsp;µg/g, <em>P</em>&nbsp;&lt;&nbsp;0.001). In conclusion, tissue exposure to infliximab is higher than that of etanercept both <em>in vivo</em> as well as in <em>ex vivo</em> perfused placentas. However, initial placental transfer, as observed <em>ex vivo</em>, does not differ between infliximab and etanercept when administered in equal amounts. The difference in placental tissue exposure to infliximab and etanercept may be of clinical relevance and warrants further investigation. More specifically, we suggest that future studies should look into the occurrence of placental TNF inhibition and possible consequences thereof.</p></section><hr class="headless">
<section class="bt xbox font-sm" id="cpt1827-blkfxd-0001"><h2 class="obj_head">Study Highlights.</h2>
<ul id="cpt1827-list-0001" class="list" style="list-style-type:none"><li><p>
<strong>WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC?</strong>
</p></li></ul>
<p>☑ The extent of placental transfer of structurally different types of tumor necrosis factor (TNF) inhibitors differs, but the underlying mechanisms are unknown. Also, it is unknown to what extent placental tissue is exposed to these drugs.
</p>
<ul id="cpt1827-list-0002" class="list" style="list-style-type:none"><li><p>
<strong>WHAT QUESTION DID THIS STUDY ADDRESS?</strong>
</p></li></ul>
<p>☑ The aim was to quantify placental exposure to infliximab and etanercept in women with autoimmune diseases, in relation to maternal and cord blood concentrations at the time of delivery. In addition, we studied the placental handling of these drugs by means of <em>ex vivo</em> placenta perfusion experiments.
</p>
<ul id="cpt1827-list-0003" class="list" style="list-style-type:none"><li><p>
<strong>WHAT DOES THIS STUDY ADD TO OUR KNOWLEDGE?</strong>
</p></li></ul>
<p>☑ Tissue exposure to infliximab is higher than that of etanercept both in placentas exposed <em>in vivo </em>as well as in<em> ex vivo</em> perfused placentas. The initial placental transfer, as observed <em>ex vivo</em>, does not differ between infliximab and etanercept when applied in equal amounts.
</p>
<ul id="cpt1827-list-0004" class="list" style="list-style-type:none"><li><p>
<strong>HOW MIGHT THIS CHANGE CLINICAL PHARMACOLOGY OR TRANSLATIONAL SCIENCE?</strong>
</p></li></ul>
<p>☑ The difference in placental tissue exposure may translate into differential TNF inhibition, which warrants future studies that look into the possible consequences thereof.</p></section><section id="cpt1827-sec-0001"><p>Autoimmune diseases, such as rheumatoid arthritis and inflammatory bowel disease (IBD) typically affect women in their reproductive years. Both rheumatoid arthritis and IBD are associated with adverse pregnancy outcomes, such as preterm birth and low birth weight.<a href="#cpt1827-bib-0001" class="usa-link" aria-describedby="cpt1827-bib-0001" aria-expanded="false">
<sup>1</sup>
</a>, <a href="#cpt1827-bib-0002" class="usa-link" aria-describedby="cpt1827-bib-0002" aria-expanded="false">
<sup>2</sup>
</a> In women with IBD, the occurrence of disease flares during pregnancy further increases these risks.<a href="#cpt1827-bib-0003" class="usa-link" aria-describedby="cpt1827-bib-0003" aria-expanded="false">
<sup>3</sup>
</a>, <a href="#cpt1827-bib-0004" class="usa-link" aria-describedby="cpt1827-bib-0004" aria-expanded="false">
<sup>4</sup>
</a> To suppress disease activity, a trend is seen towards continuing pharmacotherapy during pregnancy. Current guidelines state that immunosuppressive drugs, such as sulfasalazine, azathioprine, and cyclosporin are considered compatible with pregnancy, whereas methotrexate and cyclophosphamide are teratogenic and should be discontinued. For novel biologics, such as anakinra and ustekinumab, discontinuation is also suggested due to a lack of human safety data.<a href="#cpt1827-bib-0005" class="usa-link" aria-describedby="cpt1827-bib-0005" aria-expanded="false">
<sup>5</sup>
</a>
</p>
<p>In women with severe disease activity, treatment with tumor necrosis factor (TNF) inhibitors may include infliximab, a full immunoglobulin G1 (IgG1) chimeric mouse/human monoclonal antibody, and etanercept, a fusion protein composed of two extracellular TNF receptor domains and an fragment crystallizable region (Fc) portion of human IgG1. Both TNF inhibitors are examples of biologics for which experience exists with use during pregnancy from more than 1,000 reported pregnancies for infliximab and approximately 300 for etanercept.<a href="#cpt1827-bib-0005" class="usa-link" aria-describedby="cpt1827-bib-0005" aria-expanded="false">
<sup>5</sup>
</a>
</p>
<p>In general, anti‐TNF therapies are considered safe during pregnancy.<a href="#cpt1827-bib-0005" class="usa-link" aria-describedby="cpt1827-bib-0005" aria-expanded="false">
<sup>5</sup>
</a>, <a href="#cpt1827-bib-0006" class="usa-link" aria-describedby="cpt1827-bib-0006" aria-expanded="false">
<sup>6</sup>
</a> Some concerns exist, however, regarding the immune status in newborns that were exposed<a href="#cpt1827-bib-0007" class="usa-link" aria-describedby="cpt1827-bib-0007" aria-expanded="false">
<sup>7</sup>
</a> and the long‐term effects on development. An increased risk of major birth defects, preterm birth, and decreased birth weight were found in women exposed to anti‐TNF therapy reported to Teratology Information Services, but it is unclear whether these are associated with anti‐TNF therapy or inadequate disease control.<a href="#cpt1827-bib-0008" class="usa-link" aria-describedby="cpt1827-bib-0008" aria-expanded="false">
<sup>8</sup>
</a> Other data on drug safety of TNF inhibitors in pregnancy are limited to small case series, which do not reflect our overall clinical experience with these types of drugs because of underreporting and selective reporting.</p>
<p>During pregnancy, therapeutic levels of TNF inhibitors in the mother are necessary, while absence of fetal exposure would be ideal. For infliximab, however, the fetal drug levels towards the end of pregnancy exceed maternal levels,<a href="#cpt1827-bib-0009" class="usa-link" aria-describedby="cpt1827-bib-0009" aria-expanded="false">
<sup>9</sup>
</a>, <a href="#cpt1827-bib-0010" class="usa-link" aria-describedby="cpt1827-bib-0010" aria-expanded="false">
<sup>10</sup>
</a> since IgG molecules are actively transported across the placenta via Fc‐receptor mediated transport. Recently, higher placental transfer of infliximab compared with adalimumab was described in 94 cases.<a href="#cpt1827-bib-0010" class="usa-link" aria-describedby="cpt1827-bib-0010" aria-expanded="false">
<sup>10</sup>
</a> In only two cases treated with etanercept, minimal placental transfer was observed.<a href="#cpt1827-bib-0011" class="usa-link" aria-describedby="cpt1827-bib-0011" aria-expanded="false">
<sup>11</sup>
</a>, <a href="#cpt1827-bib-0012" class="usa-link" aria-describedby="cpt1827-bib-0012" aria-expanded="false">
<sup>12</sup>
</a> Altogether, this points to differences in placental transfer which we do not fully understand mechanistically.</p>
<p>In addition, placental exposure to TNF inhibitors has not been investigated, while it may be another important determinant of adverse pregnancy outcome. As the placenta is extensively vascularized, it may be more exposed to drugs than other tissues, making it a potential target organ for toxicity. Also, TNF is highly regulated during pregnancy and plays an important role in placental function.<a href="#cpt1827-bib-0013" class="usa-link" aria-describedby="cpt1827-bib-0013" aria-expanded="false">
<sup>13</sup>
</a>
</p>
<p>As our understanding of placental transfer and, in particular, placental tissue exposure to structurally different TNF inhibitors is limited, it is important to support the existing data with mechanistic studies that also involve preclinical models on their placental handling. In this study, we investigated placental transfer and placental exposure in six patients treated with infliximab or etanercept throughout pregnancy and compared these findings with those of short‐term exposure in <em>ex vivo</em> placenta perfusion experiments.</p></section><section id="cpt1827-sec-0002"><h2 class="pmc_sec_title" data-anchor-id="cpt1827-sec-0002"><a id="cpt1827-sec-0002-anchor" data-anchor-id="cpt1827-sec-0002" class="usa-anchor"></a>Methods</h2>
<section id="cpt1827-sec-0003"><h3 class="pmc_sec_title">Study population</h3>
<p>Six pregnant women treated with either infliximab (<em>n</em>&nbsp;=&nbsp;3) or etanercept (<em>n</em>&nbsp;=&nbsp;3) for autoimmune disease throughout pregnancy were enrolled in this study, which was approved by the Regional Committee on Research involving Human Subjects (file no. 2016‐2744). Written informed consent was obtained at routine prenatal care visits from 30&nbsp;weeks of pregnancy onwards. Descriptive data on medication use and pregnancy outcome were retrieved from medical files retrospectively.</p>
<p>Nine healthy pregnant women were enrolled in this study for <em>ex vivo</em> placenta perfusion experiments with infliximab (<em>n</em>&nbsp;=&nbsp;4) or etanercept (<em>n</em>&nbsp;=&nbsp;5). Medical‐ethical approval was also acquired for these experiments (file no. 2014‐1397), and data on pregnancy outcome were retrieved from medical files (<strong>Table&nbsp;</strong>
<a href="#cpt1827-sup-0001" class="usa-link">
<strong>S1</strong>
</a>).</p></section><section id="cpt1827-sec-0004"><h3 class="pmc_sec_title">Blood and placenta sample collection</h3>
<p>Maternal and cord blood samples were collected on the day of delivery. Serum was stored at −80°C until analysis. The placenta was stored at 4°C directly after delivery and 1&nbsp;cm<sup>3</sup> sized samples of villous tissue were excised, snap frozen, and stored at −80°C within 24&nbsp;hours.</p></section><section id="cpt1827-sec-0005"><h3 class="pmc_sec_title">
<em>Ex vivo</em> placenta perfusions</h3>
<p>Placentas from healthy women were used for <em>ex vivo</em> placenta perfusions based on the method described by Mathiesen <em>et al</em>.<a href="#cpt1827-bib-0014" class="usa-link" aria-describedby="cpt1827-bib-0014" aria-expanded="false">
<sup>14</sup>
</a> Briefly, a branch of the umbilical artery and an associated vein from a single cotyledon were cannulated to reestablish the fetal circulation. The fetal flow rate was slowly increased to 6&nbsp;mL/minute. If no measurable leakage occurred, the placental cotyledon was cut from the placenta and placed in the perfusion setup. Then, the maternal circulation of 12&nbsp;mL/minute was established by inserting four cannulas on the maternal side of the cotyledon and recirculating the fluid that leaked from the intervillous space. During cannulation, the placentas were flushed for 30–60&nbsp;minutes with Krebs‐Henseleit buffer enriched with 10.1&nbsp;mM glucose and 0.5&nbsp;mL/L heparin 5,000&nbsp;IU in open circulation. The Krebs buffer was then changed to the experimental perfusion solutions, and the circulations were closed. When changing the buffers, approximately 20&nbsp;mL of Krebs buffer mixed with each experiment buffer, since this is the dead volume of the perfusion system. The maternal solution consisted of RPMI 1640 culture medium (catalog no. R8758, Sigma, St Louis, MO) with infliximab (Remsima, Mundipharma, Amersfoort, The Netherlands) (10&nbsp;mg/mL) or etanercept (Enbrel, Pfizer, Dublin, Ireland) (10&nbsp;mg/mL) in a final concentration of 100&nbsp;mg/L, antipyrine (100&nbsp;mg/L), human albumin (29&nbsp;g/L) (Albuman, Sanquin, Amsterdam, The Netherlands), and 1% penicillin and streptomycin. Infliximab and etanercept have an equal molecular weight and for comparison of their disposition, equal amounts were applied in the placenta perfusions. The fetal solution consisted of RPMI culture medium with human albumin (34&nbsp;g/L) (Albuman, Sanquin, Amsterdam, The Netherlands) and 1% penicillin and streptomycin. Maternal perfusion solutions were gassed with 95% oxygen / 5% carbon dioxide and fetal perfusion solutions with 95% nitrogen / 5% carbon dioxide. All solutions were continuously kept at 37°C, while pH was monitored and kept at 7.4. Placentas were perfused for 6&nbsp;hours, during which the buffer volume was monitored and 15 samples were taken over time of both maternal and fetal buffers. These were centrifuged for 5&nbsp;minutes at 3,000&nbsp;<em>g</em> and the supernatant was stored at −20°C. In addition, three samples of 1&nbsp;cm<sup>3</sup> of villous tissue from the perfused cotyledon were collected, snap frozen, and stored at −80°C. Infliximab and etanercept levels were quantified as outlined below. Control experiments were performed for both TNF inhibitors by carrying out the perfusion experiment in absence of a placenta.</p></section><section id="cpt1827-sec-0006"><h3 class="pmc_sec_title">Quantification of infliximab and etanercept in serum, perfusion buffers, and tissue homogenates</h3>
<p>Infliximab and etanercept levels in serum were quantified by enzyme‐linked immunosorbent assay&nbsp;performed by Sanquin Diagnostic Services (Amsterdam, The Netherlands). Over the investigated concentration range, the method for infliximab exhibited an accuracy and precision of 94–108% and 4–8%, respectively. For etanercept, the respective accuracy and precision in serum were 92–103% and 10–17%. The lower limits of quantification were 0.03&nbsp;µg/mL and 0.1&nbsp;µg/mL for infliximab and etanercept, respectively.<a href="#cpt1827-bib-0015" class="usa-link" aria-describedby="cpt1827-bib-0015" aria-expanded="false">
<sup>15</sup>
</a>, <a href="#cpt1827-bib-0016" class="usa-link" aria-describedby="cpt1827-bib-0016" aria-expanded="false">
<sup>16</sup>
</a> Perfusate samples were analyzed in the same manner, and we found recoveries for infliximab and etanercept from the perfusion buffer of 76&nbsp;±&nbsp;16% and 73&nbsp;±&nbsp;8% in the starting solutions prepared at a concentration of 110&nbsp;µg/mL. Briefly, microtiter plates were coated with a mouse monoclonal antibody against TNF and recombinant TNF was added. Samples were added and subsequently incubated with a horseradish peroxidase conjugated monoclonal antihuman IgG (infliximab assay) or idiotypic specific monoclonal antibody (etanercept assay). Color reaction with tetramethylbenzidine was related to a standard curve and samples were back‐calculated.<a href="#cpt1827-bib-0015" class="usa-link" aria-describedby="cpt1827-bib-0015" aria-expanded="false">
<sup>15</sup>
</a>, <a href="#cpt1827-bib-0016" class="usa-link" aria-describedby="cpt1827-bib-0016" aria-expanded="false">
<sup>16</sup>
</a>, <a href="#cpt1827-bib-0017" class="usa-link" aria-describedby="cpt1827-bib-0017" aria-expanded="false">
<sup>17</sup>
</a>
</p>
<p>The above method was also applied to the tissue homogenate supernatants. Briefly, 20% placental tissue homogenates (based on tissue wet weight) were prepared in RIPA buffer containing 5&nbsp;mM Tris‐HCl buffer pH 7.4, 150&nbsp;mM sodium chloride, 1% Triton‐X100&nbsp;(catalog no 23,472‐9, Sigma, St Louis, MO), 0.5% sodium deoxycholate, and one Roche complete proteinase inhibitor tablet per 10&nbsp;mL buffer (catalog no. 04693116001, Sigma, St Louis, MO). Homogenates were prepared with a T10 basic Ultra‐Turrax disperser (IKA, Staufen, Germany), and the samples were kept on ice during homogenization. After homogenization, the samples were mixed and kept on ice for 1 hour, after which they were mixed again and centrifuged for 5&nbsp;minutes at 5,000&nbsp;<em>g</em>. The supernatant was stored at −80°C until analysis. To investigate the performance of the analytical method, 20% blanc homogenates were spiked in triplicate with 1, 3, and 10&nbsp;mg/L concentrations of infliximab and etanercept after which the accuracy and precision of the analysis method were assessed. Additionally, we studied the stability of etanercept and infliximab in tissue homogenates stored at 4°C for 24&nbsp;hours, which would conveniently allow for storage of the placenta at 4°C after birth, before further processing the next day. Infliximab and etanercept could be measured accurately and with good precision and remained stable for 24&nbsp;hours at 4°C using the sample preparation procedure described (<strong>Table&nbsp;</strong>
<a href="#cpt1827-sup-0001" class="usa-link">
<strong>S2</strong>
</a>). To allow for measuring within the range of the assay, homogenates for etanercept were also prepared as a 50% homogenate.</p></section><section id="cpt1827-sec-0007"><h3 class="pmc_sec_title">Antipyrine measurements</h3>
<p>In all placenta perfusion experiments, antipyrine transfer was used as a parameter for free diffusion to check if the cannulation procedure was successful. To quantify antipyrine in placental tissue, a 20% homogenate in ultrapure water was prepared. Next, placental homogenate samples or perfusion buffer samples were deproteinized with 6% perchloric acid and spun. A reaction mix consisting of 0.2&nbsp;mg/mL sodium nitrite and 0.6% concentrated sulfuric acid was added to the supernatants (1:1). The nitroantipyrine that was formed was determined via absorbance measurements at 350&nbsp;nm against calibration curves constructed in the corresponding matrix.</p></section><section id="cpt1827-sec-0008"><h3 class="pmc_sec_title">Data analyses</h3>
<p>Placental tissue samples consist by definition of placental tissue as well as fetal and maternal blood or buffer that is present within the tissue. Hence, the concentrations measured in the homogenates were corrected for TNF inhibitor concentrations present in buffer/blood, to better reflect the biological concentrations in the actual tissue. We assumed that the homogenate consisted of 80% placental tissue, 12% maternal blood or buffer, and 8% fetal blood or buffer, based on earlier work by Barker <em>et al</em>. This resulted in the following formula for correction:<a href="#cpt1827-bib-0018" class="usa-link" aria-describedby="cpt1827-bib-0018" aria-expanded="false">
<sup>18</sup>
</a>
</p>
<table class="disp-formula p" id="cpt1827-disp-0001"><tbody><tr><td class="formula"><mjx-container class="CtxtMenu_Attached_0" tabindex="0" ctxtmenu_counter="0"><mjx-lazy data-mjx-lazy="0"></mjx-lazy></mjx-container></td></tr></tbody></table>
<p>Serum concentrations were first recalculated to maternal or fetal whole blood concentrations by multiplying with the serum fraction relative to hematocrit in whole blood, which is 0.65 for maternal samples and 0.54 for fetal samples.<a href="#cpt1827-bib-0019" class="usa-link" aria-describedby="cpt1827-bib-0019" aria-expanded="false">
<sup>19</sup>
</a>, <a href="#cpt1827-bib-0020" class="usa-link" aria-describedby="cpt1827-bib-0020" aria-expanded="false">
<sup>20</sup>
</a> We assumed that partition of biologicals into hematocrit did not occur.</p>
<p>To express placental transfer, cord‐to‐maternal ratios were calculated using serum levels. To express tissue exposure, placenta‐to‐maternal ratios were calculated by dividing the average corrected placental tissue concentration by the maternal whole blood or buffer concentrations. For placenta perfusion experiments, fetal volume loss was estimated by comparing the measured buffer volume with the nominal volume that should be present in the fetal or maternal perfusate circulation, taking into account the sampling volume. Graphs were constructed using GraphPad Prism software version 5.03 (GraphPad, San Diego, CA). Results are presented as mean&nbsp;±&nbsp;SD or the individual data points and the means are plotted. For statistical analysis of the placenta perfusion data, a one‐way analysis of variance was used to compare placenta‐to‐maternal ratios and an unpaired <em>t</em>‐test was performed to compare drug concentrations in placenta tissue.</p></section></section><section id="cpt1827-sec-0009"><h2 class="pmc_sec_title" data-anchor-id="cpt1827-sec-0009"><a id="cpt1827-sec-0009-anchor" data-anchor-id="cpt1827-sec-0009" class="usa-anchor"></a>Results</h2>
<section id="cpt1827-sec-0010"><h3 class="pmc_sec_title">Subject characteristics</h3>
<p>We included six pregnant patients treated with either infliximab or etanercept. In <strong>Table&nbsp;</strong>
<a href="#cpt1827-tbl-0001" class="usa-link">
<strong>1</strong>
</a>, the patient characteristics are presented. Age was between 25 and 37&nbsp;years, and none of the patients smoked. Most pregnancies were uncomplicated and reached full‐term delivery. One patient had a caesarean section. All neonates were born with a birth weight within normal limits (10<sup>th</sup>–90<sup>th</sup> percentile) and had an uncomplicated hospital stay, although one neonate was suspected for infection.</p>
<section class="tw xbox font-sm" id="cpt1827-tbl-0001" lang="en"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Subject characteristics</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup><col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
</colgroup><thead valign="top"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="top" rowspan="1" colspan="1">Patient</th>
<th align="center" valign="top" rowspan="1" colspan="1">Age (years)</th>
<th align="center" valign="top" rowspan="1" colspan="1">Pre‐pregnancy BMI (kg/m<sup>2</sup>)</th>
<th align="center" valign="top" rowspan="1" colspan="1">Auto immune disease</th>
<th align="center" valign="top" rowspan="1" colspan="1">Comorbidity</th>
<th align="center" valign="top" rowspan="1" colspan="1">Pregnancy complications</th>
<th align="center" valign="top" rowspan="1" colspan="1">Medication during pregnancy</th>
<th align="center" valign="top" rowspan="1" colspan="1">Gestational age at delivery (weeks)</th>
<th align="center" valign="top" rowspan="1" colspan="1">Birth weight neonate (percentile range)</th>
<th align="center" valign="top" rowspan="1" colspan="1">Neonatal complications</th>
</tr></thead>
<tbody>
<tr>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">37</td>
<td align="center" rowspan="1" colspan="1">21.5</td>
<td align="center" rowspan="1" colspan="1">Rheumatoid arthritis</td>
<td align="center" rowspan="1" colspan="1">
<p>Primary hypothyroidism</p>
<p>Partial androgen insensitivity syndrome</p>
<p>Uveitis</p>
<p>Vitiligo</p>
</td>
<td align="center" rowspan="1" colspan="1">None</td>
<td align="center" rowspan="1" colspan="1">
<p>Infliximab</p>
<p>Azathioprine</p>
<p>Levothyroxine</p>
</td>
<td align="center" rowspan="1" colspan="1">40<sup>+1</sup>
</td>
<td align="center" rowspan="1" colspan="1">4050&nbsp;g (p50–90)</td>
<td align="center" rowspan="1" colspan="1">None</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">27</td>
<td align="center" rowspan="1" colspan="1">22.3</td>
<td align="center" rowspan="1" colspan="1">Crohn's disease</td>
<td align="center" rowspan="1" colspan="1">Asthma</td>
<td align="center" rowspan="1" colspan="1">None</td>
<td align="center" rowspan="1" colspan="1">Infliximab</td>
<td align="center" rowspan="1" colspan="1">41<sup>+6</sup>
</td>
<td align="center" rowspan="1" colspan="1">3715&nbsp;g (p10–50)</td>
<td align="center" rowspan="1" colspan="1">None</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">25</td>
<td align="center" rowspan="1" colspan="1">24.7</td>
<td align="center" rowspan="1" colspan="1">Crohn's disease</td>
<td align="center" rowspan="1" colspan="1">None</td>
<td align="center" rowspan="1" colspan="1">None</td>
<td align="center" rowspan="1" colspan="1">Infliximab, Hydroxocobalamin</td>
<td align="center" rowspan="1" colspan="1">38<sup>+6</sup>
</td>
<td align="center" rowspan="1" colspan="1">3100&nbsp;g (p10–50)</td>
<td align="center" rowspan="1" colspan="1">None</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">30</td>
<td align="center" rowspan="1" colspan="1">21.5</td>
<td align="center" rowspan="1" colspan="1">Ankylosing spondylitis</td>
<td align="center" rowspan="1" colspan="1">Attention deficit disorder</td>
<td align="center" rowspan="1" colspan="1">Preeclampsia</td>
<td align="center" rowspan="1" colspan="1">
<p>Etanercept</p>
<p>Nitrofurantoin</p>
<p>Methyldopa</p>
</td>
<td align="center" rowspan="1" colspan="1">38<sup>+5</sup>
</td>
<td align="center" rowspan="1" colspan="1">3305&nbsp;g (p50–90)</td>
<td align="center" rowspan="1" colspan="1">Suspicion for infection</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">31</td>
<td align="center" rowspan="1" colspan="1">24.4</td>
<td align="center" rowspan="1" colspan="1">Rheumatoid arthritis</td>
<td align="center" rowspan="1" colspan="1">None</td>
<td align="center" rowspan="1" colspan="1">None</td>
<td align="center" rowspan="1" colspan="1">Etanercept</td>
<td align="center" rowspan="1" colspan="1">40<sup>+6</sup>
</td>
<td align="center" rowspan="1" colspan="1">3780&nbsp;g (p10–50)</td>
<td align="center" rowspan="1" colspan="1">None</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">37</td>
<td align="center" rowspan="1" colspan="1">23.1</td>
<td align="center" rowspan="1" colspan="1">Psoriasis vulgaris</td>
<td align="center" rowspan="1" colspan="1">None</td>
<td align="center" rowspan="1" colspan="1">None</td>
<td align="center" rowspan="1" colspan="1">Etanercept</td>
<td align="center" rowspan="1" colspan="1">39<sup>+1</sup>
</td>
<td align="center" rowspan="1" colspan="1">3780&nbsp;g (p50–90)</td>
<td align="center" rowspan="1" colspan="1">None</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/cpt1827-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="cpt1827-note-0001"><p>p,&nbsp;percentile.</p></div></div></section></section><section id="cpt1827-sec-0011"><h3 class="pmc_sec_title">
<em>In vivo</em> placental transfer and exposure</h3>
<section id="cpt1827-sec-0012"><h4 class="pmc_sec_title">Infliximab</h4>
<p>All patients were on standard infliximab treatment of 5&nbsp;mg/kg every 8&nbsp;weeks and received the last infliximab dose 23, 31, or 57&nbsp;days prior to delivery. Infliximab levels in cord blood exceeded the maternal levels. Infliximab was detectable in all placentas and was distributed homogeneously within the tissue with average drug levels of 5.8&nbsp;±&nbsp;0.9, 4.8&nbsp;±&nbsp;1.5, and 1.8&nbsp;±&nbsp;0.0&nbsp;μg/g tissue per placenta. Placental concentrations were lower than maternal or cord blood concentrations at delivery and placenta‐to‐maternal ratios were on average 0.34&nbsp;±&nbsp;0.11. The data are summarized in <strong>Table&nbsp;</strong>
<a href="#cpt1827-tbl-0002" class="usa-link">
<strong>2</strong>
</a>, and represent tissue concentrations after correction for blood‐associated infliximab concentrations. The uncorrected results can be found in <strong>Table&nbsp;</strong>
<a href="#cpt1827-sup-0001" class="usa-link">
<strong>S3</strong>
</a>.</p>
<section class="tw xbox font-sm" id="cpt1827-tbl-0002" lang="en"><h5 class="obj_head">Table 2.</h5>
<div class="caption p"><p>Placental transfer and placental exposure to infliximab and etanercept in patients with autoimmune diseases</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup><col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
<col style="border-right:solid 1px #000000" span="1">
</colgroup><thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="3" valign="bottom" colspan="1">Patient</th>
<th align="center" rowspan="3" valign="bottom" colspan="1">TNF inhibitor</th>
<th align="center" rowspan="3" valign="bottom" colspan="1">Dosing regimen</th>
<th align="center" rowspan="3" valign="bottom" colspan="1">Time from last dose to delivery (days)</th>
<th align="center" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">TNF inhibitor</th>
<th align="center" rowspan="3" valign="bottom" colspan="1">Cord‐to‐maternal ratio</th>
<th align="center" rowspan="3" valign="bottom" colspan="1">Placenta‐to‐maternal ratio</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="center" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">(µg/mL serum)</th>
<th align="center" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Mean&nbsp;±&nbsp;SD (µg/g tissue)</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="center" valign="bottom" rowspan="1" colspan="1">Maternal</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Cord</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Placenta</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="2" colspan="1">1</td>
<td align="center" rowspan="2" colspan="1">Infliximab</td>
<td align="center" rowspan="1" colspan="1">400&nbsp;mg per 8&nbsp;weeks</td>
<td align="center" rowspan="2" colspan="1">23</td>
<td align="center" rowspan="2" colspan="1">25.3</td>
<td align="center" rowspan="2" colspan="1">29.8</td>
<td align="center" rowspan="2" colspan="1">5.8&nbsp;±&nbsp;0.9</td>
<td align="center" rowspan="2" colspan="1">1.18</td>
<td align="center" rowspan="2" colspan="1">0.35</td>
</tr>
<tr><td align="center" rowspan="1" colspan="1">(5&nbsp;mg/kg)</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1">2</td>
<td align="center" rowspan="2" colspan="1">Infliximab</td>
<td align="center" rowspan="1" colspan="1">400&nbsp;mg per 8&nbsp;weeks</td>
<td align="center" rowspan="2" colspan="1">57</td>
<td align="center" rowspan="2" colspan="1">12.0</td>
<td align="center" rowspan="2" colspan="1">24.0</td>
<td align="center" rowspan="2" colspan="1">1.8&nbsp;±&nbsp;0.0</td>
<td align="center" rowspan="2" colspan="1">2.00</td>
<td align="center" rowspan="2" colspan="1">0.23</td>
</tr>
<tr><td align="center" rowspan="1" colspan="1">(5&nbsp;mg/kg)</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1">3</td>
<td align="center" rowspan="2" colspan="1">Infliximab</td>
<td align="center" rowspan="1" colspan="1">400&nbsp;mg per 8&nbsp;weeks</td>
<td align="center" rowspan="2" colspan="1">31</td>
<td align="center" rowspan="2" colspan="1">17.0</td>
<td align="center" rowspan="2" colspan="1">29.0</td>
<td align="center" rowspan="2" colspan="1">4.8&nbsp;±&nbsp;1.5</td>
<td align="center" rowspan="2" colspan="1">1.71</td>
<td align="center" rowspan="2" colspan="1">0.44</td>
</tr>
<tr><td align="center" rowspan="1" colspan="1">(5&nbsp;mg/kg)</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">Etanercept</td>
<td align="center" rowspan="1" colspan="1">50&nbsp;mg per 12&nbsp;days</td>
<td align="center" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">3.0</td>
<td align="center" rowspan="1" colspan="1">0.1</td>
<td align="center" rowspan="1" colspan="1">0.1&nbsp;±&nbsp;0.1</td>
<td align="center" rowspan="1" colspan="1">0.04</td>
<td align="center" rowspan="1" colspan="1">0.03</td>
</tr>
<tr style="border-bottom:solid 1px #000000">
<td align="left" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">Etanercept</td>
<td align="center" rowspan="1" colspan="1">50&nbsp;mg per week</td>
<td align="center" rowspan="1" colspan="1">29</td>
<td align="center" rowspan="1" colspan="1">&lt;0.1</td>
<td align="center" rowspan="1" colspan="1">&lt;0.1</td>
<td align="center" rowspan="1" colspan="1">&lt;0.1</td>
<td align="center" rowspan="1" colspan="1">NA</td>
<td align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">&nbsp;6</td>
<td align="center" rowspan="1" colspan="1">Etanercept</td>
<td align="center" rowspan="1" colspan="1">50&nbsp;mg per week</td>
<td align="center" rowspan="1" colspan="1">16</td>
<td align="center" rowspan="1" colspan="1">0.2</td>
<td align="center" rowspan="1" colspan="1">NA</td>
<td align="center" rowspan="1" colspan="1">&lt;0.1</td>
<td align="center" rowspan="1" colspan="1">NA</td>
<td align="center" rowspan="1" colspan="1">NA</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/cpt1827-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="cpt1827-note-0003"><p>Placental transfer is represented as cord‐to‐maternal ratios based on serum levels, and placental exposure is calculated as placenta‐to‐maternal ratios based on placental tissue concentrations corrected for serum levels and maternal calculated whole blood concentrations. Cord blood of patient 6 was not available.</p></div>
<div class="fn" id="cpt1827-note-0002"><p>NA, not assessed; TNF, tumor necrosis factor.</p></div>
</div></section></section><section id="cpt1827-sec-0013"><h4 class="pmc_sec_title">Etanercept</h4>
<p>All patients received 50&nbsp;mg etanercept every 7–12&nbsp;days. Etanercept drug levels were detectable in maternal blood, cord blood, and placental tissue of one patient who received the last etanercept dose 4&nbsp;days before delivery. The cord‐to‐maternal ratio was 0.04, indicating limited placental passage. Etanercept concentrations in the placenta were 0.1&nbsp;±&nbsp;0.1&nbsp;μg/g when corrected for serum levels, equaling a placenta‐to‐maternal ratio of 0.03. In the second patient, the final etanercept administration was 29&nbsp;days before delivery and etanercept was not detected in any sample. In the third patient, final etanercept administration was 16&nbsp;days before delivery. The maternal etanercept concentration was 0.2&nbsp;μg/mL, but no levels could be detected in the placenta. For this patient, cord blood was not collected (<strong>Table&nbsp;</strong>
<a href="#cpt1827-tbl-0002" class="usa-link">
<strong>2</strong>
</a> and <strong>Table&nbsp;</strong>
<a href="#cpt1827-sup-0001" class="usa-link">
<strong>S3</strong>
</a>). In patients 5 and 6, discontinuation of etanercept before delivery may have been intentional to limit fetal exposure.</p></section></section><section id="cpt1827-sec-0014"><h3 class="pmc_sec_title">
<em>Ex vivo</em> placental transfer and exposure to infliximab and etanercept</h3>
<p>Nine successful <em>ex vivo</em> placenta perfusions were conducted (infliximab <em>n</em>&nbsp;=&nbsp;4, etanercept <em>n</em>&nbsp;=&nbsp;5). <strong>Figure&nbsp;</strong>
<a href="#cpt1827-fig-0001" class="usa-link">
<strong>1</strong>
</a> displays (<strong>a</strong>) the placental transfer of infliximab and (<strong>b</strong>) the corresponding final concentrations in each compartment. The initial average maternal infliximab concentration was 83&nbsp;±&nbsp;18&nbsp;µg/mL, and the final maternal concentration (72&nbsp;±&nbsp;12&nbsp;µg/ml) did not substantially differ from that at 1&nbsp;hour. Still, placental exposure could be measured with infliximab concentrations in tissue reaching 19&nbsp;±&nbsp;6&nbsp;µg/g, corrected for infliximab concentrations associated with perfusion buffer remaining in the tissue. Infliximab was first detected in the fetal circulation after 2–4&nbsp;hours, and final concentrations were 0.3&nbsp;±&nbsp;0.3&nbsp;µg/mL, which points to slow placental transfer.</p>
<figure class="fig xbox font-sm" id="cpt1827-fig-0001" lang="en"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f7b/7325311/e1d6eb0a7e38/CPT-108-99-g001.jpg" loading="lazy" id="nlm-graphic-1" height="345" width="709" alt="Figure 1"></p>
<div class="p text-right font-secondary"><a href="figure/cpt1827-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>
<em>Ex vivo</em> placental transfer of (<strong>a</strong>) infliximab and (<strong>b</strong>) final infliximab distribution across the different compartments after 6&nbsp;hours placenta perfusion. Mean and individual experiments are represented. Placental concentrations are the average of three samples per perfused placenta and are corrected for buffer‐associated drug concentrations. [Colour figure can be viewed at <a href="http://wileyonlinelibrary.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">wileyonlinelibrary.com</a>]</p></figcaption></figure><p>Placental transfer of etanercept and final etanercept concentrations per compartment can be found in <strong>Figure&nbsp;</strong>
<a href="#cpt1827-fig-0002" class="usa-link">
<strong>2</strong>
</a>
<strong>a,b</strong>, respectively. Initial maternal etanercept concentrations were 80&nbsp;±&nbsp;9&nbsp;μg/mL, and final concentrations were 43&nbsp;±&nbsp;22 (range: 5.7–61) μg/mL. Etanercept concentrations in placental tissue were on average 1&nbsp;±&nbsp;3&nbsp;µg/g. In four placenta perfusions, tissue concentrations ranged from 1.2 to 4.9&nbsp;μg/g, whereas in one placenta perfusion measured tissue levels were negligible and could be explained by the concentrations in the maternal and fetal buffers (<strong>Figure&nbsp;</strong>
<a href="#cpt1827-fig-0002" class="usa-link">
<strong>2</strong>
</a>
<strong>b</strong>). In two experiments, fetal etanercept remained below the detection limit of 0.1&nbsp;µg/mL for 6&nbsp;hours. In the other experiments, the first detectable fetal etanercept levels were seen after 1–3&nbsp;hours. On average, final etanercept concentrations in the fetal compartment were 0.2&nbsp;±&nbsp;0.2&nbsp;μg/mL, again pointing to a slow but detectable placental transfer comparable to infliximab.</p>
<figure class="fig xbox font-sm" id="cpt1827-fig-0002" lang="en"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f7b/7325311/5abef9bfdeb6/CPT-108-99-g002.jpg" loading="lazy" id="nlm-graphic-3" height="358" width="709" alt="Figure 2"></p>
<div class="p text-right font-secondary"><a href="figure/cpt1827-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>
<em>Ex vivo</em> placental transfer of (<strong>a</strong>) etanercept and (<strong>b</strong>) final etanercept distribution across the different compartments after 6&nbsp;hours placenta perfusion. Mean and individual experiments are represented. Placental concentrations are the average of three samples per perfused placenta and are corrected for buffer‐associated drug concentrations. [Colour figure can be viewed at <a href="http://wileyonlinelibrary.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">wileyonlinelibrary.com</a>]</p></figcaption></figure><p>Antipyrine concentrations reached an equilibrium between the maternal and fetal circulations within 2.5 hours in all placenta perfusions (<strong>Figure&nbsp;</strong>
<a href="#cpt1827-fig-0003" class="usa-link">
<strong>3</strong>
</a>
<strong>a</strong>), confirming successful cannulation. After 6&nbsp;hours of perfusion, antipyrine concentrations in maternal, fetal, and placental compartments were 44&nbsp;±&nbsp;5&nbsp;μg/mL, 39&nbsp;±&nbsp;3&nbsp;μg/mL, and 32&nbsp;±&nbsp;6&nbsp;μg/g, respectively, showing that antipyrine distributes across all three compartments (<strong>Figure&nbsp;</strong>
<a href="#cpt1827-fig-0003" class="usa-link">
<strong>3</strong>
</a>
<strong>b</strong>). Since both infliximab and etanercept could be detected in placental tissue from <em>ex vivo</em> perfusion experiments, placenta‐to‐maternal ratios were calculated to evaluate differences in placental exposure using antipyrine as a reference (<strong>Figure&nbsp;</strong>
<a href="#cpt1827-fig-0004" class="usa-link">
<strong>4</strong>
</a>). Placenta‐to‐maternal ratios of antipyrine, infliximab, and etanercept were 0.74&nbsp;±&nbsp;0.12, 0.28&nbsp;±&nbsp;0.11, and 0.2&nbsp;±&nbsp;0.4, respectively. The placental exposure to antipyrine largely exceeded the exposure to infliximab and etanercept (<em>P</em>&nbsp;&lt;&nbsp;0.001). Absolute placental tissue concentrations of infliximab were higher than those of etanercept (<em>P</em>&nbsp;&lt;&nbsp;0.001).</p>
<figure class="fig xbox font-sm" id="cpt1827-fig-0003" lang="en"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f7b/7325311/a5925b53b59f/CPT-108-99-g003.jpg" loading="lazy" id="nlm-graphic-5" height="347" width="709" alt="Figure 3"></p>
<div class="p text-right font-secondary"><a href="figure/cpt1827-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>
<em>Ex vivo</em> placental transfer of (<strong>a</strong>)&nbsp;antipyrine in all placenta perfusions &nbsp;and (<strong>b</strong>) its final distribution across the perfusion compartments after 6 hours of perfusion (n = 9). Data points represent <strong>a</strong>&nbsp;mean&nbsp;±&nbsp;SD&nbsp;or <strong>b</strong> the average of three samples per perfused placenta which are&nbsp;corrected for buffer‐associated drug concentrations. In all placenta perfusions, antipyrine levels show good overlap within 2.5&nbsp;hours of perfusion, confirming a successful cannulation procedure. [Colour figure can be viewed at <a href="http://wileyonlinelibrary.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">wileyonlinelibrary.com</a>]</p></figcaption></figure><figure class="fig xbox font-sm" id="cpt1827-fig-0004" lang="en"><h4 class="obj_head">Figure 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f7b/7325311/561c7ac9a9cd/CPT-108-99-g004.jpg" loading="lazy" id="nlm-graphic-7" height="683" width="709" alt="Figure 4"></p>
<div class="p text-right font-secondary"><a href="figure/cpt1827-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Placental exposure to antipyrine, infliximab, and etanercept as reflected by placenta‐to‐maternal ratios for each placenta perfusion experiment. [Colour figure can be viewed at <a href="http://wileyonlinelibrary.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">wileyonlinelibrary.com</a>]</p></figcaption></figure></section><section id="cpt1827-sec-0015"><h3 class="pmc_sec_title">Quality control criteria in placenta perfusion experiments</h3>
<p>All placenta perfusions had fetal volume loss to some extent, mostly occurring after three hours of perfusion with total volume loss ranging from 4 to 28&nbsp;mL (<strong>Figure&nbsp;</strong>
<a href="#cpt1827-sup-0001" class="usa-link">
<strong>S1</strong>
</a>), corresponding to on average 0.7–4.7&nbsp;mL/hour, which we found acceptable. A certain loss of volume is inherent to the perfusion system and may point to an impaired vascular integrity. If this were the case, it would impact both drugs equally as mean volume loss did not significantly differ between infliximab and etanercept placenta perfusions. In control perfusions without the presence of a placenta, we found that infliximab levels remained stable in the perfusion system up to 6&nbsp;hours. However, etanercept concentrations decreased to approximately 50% of the initially added concentration (<strong>Figure&nbsp;</strong>
<a href="#cpt1827-sup-0001" class="usa-link">
<strong>S1</strong>
</a>), indicating that etanercept is either unstable in 6‐hour placenta perfusions or displays adherence to components of the perfusion system. To this end, we assessed the stability of etanercept at 37°C in perfusion buffer and found recoveries of 113%, 112%, and 114% of control, after 1, 3, and 6&nbsp;hours of incubation in standard reaction vials, respectively.</p></section></section><section id="cpt1827-sec-0016"><h2 class="pmc_sec_title" data-anchor-id="cpt1827-sec-0016"><a id="cpt1827-sec-0016-anchor" data-anchor-id="cpt1827-sec-0016" class="usa-anchor"></a>Discussion</h2>
<p>Exposure of placental tissue to TNF inhibitors may be an important determinant of adverse pregnancy outcome. To this end, we studied placental drug concentrations in relation to maternal and cord blood concentrations in women who continued TNF inhibitor therapy during pregnancy. In addition, we used <em>ex vivo</em> placenta perfusions to study placental handling of TNF inhibitors in the first hours after initial exposure. We found that at delivery, infliximab can be readily detected in the placenta, whereas etanercept concentrations were much lower to undetectable. In <em>ex vivo</em> perfused placentas, tissue concentrations of both TNF inhibitors were found. Here, infliximab levels exceeded those of etanercept, while placental transfer of both biologics was comparable.</p>
<p>Placental concentrations of TNF inhibitors may be placed in perspective by comparison to levels observed in other tissues, in which therapeutic responses are observed upon clinical dosing. Tissue levels of TNF inhibitors have not been studied widely, but infliximab levels in gut biopsies obtained 2 weeks after administration were determined by Yoshihara <em>et al</em>.<a href="#cpt1827-bib-0021" class="usa-link" aria-describedby="cpt1827-bib-0021" aria-expanded="false">
<sup>21</sup>
</a> They observed median drug levels of 1.7 and 1.0&nbsp;µg/g in inflamed and uninflamed bowel tissue, respectively.<a href="#cpt1827-bib-0021" class="usa-link" aria-describedby="cpt1827-bib-0021" aria-expanded="false">
<sup>21</sup>
</a> We found 1.8–5.8&nbsp;μg/g in exposed placentas (final dose: 23–57&nbsp;days before delivery), indicating pharmacologically relevant placental exposure levels, which are also in line with target serum trough levels of 5&nbsp;µg/mL.<a href="#cpt1827-bib-0022" class="usa-link" aria-describedby="cpt1827-bib-0022" aria-expanded="false">
<sup>22</sup>
</a> Consistent with previous studies, we found that infliximab cord blood levels largely exceed maternal drug levels.<a href="#cpt1827-bib-0009" class="usa-link" aria-describedby="cpt1827-bib-0009" aria-expanded="false">
<sup>9</sup>
</a>, <a href="#cpt1827-bib-0010" class="usa-link" aria-describedby="cpt1827-bib-0010" aria-expanded="false">
<sup>10</sup>
</a> Thus, in pregnant women treated with infliximab, both fetal and placental exposure may be of pharmacological relevance.</p>
<p>For etanercept, we were able to detect a placental concentration in one patient only, who received etanercept shortly (4&nbsp;days) before delivery. Tissue distribution of etanercept in rats was found to be 7–15% of plasma levels, depending on the type of tissue.<a href="#cpt1827-bib-0023" class="usa-link" aria-describedby="cpt1827-bib-0023" aria-expanded="false">
<sup>23</sup>
</a> No placental tissue was studied, but the order of magnitude of tissue exposure appears in line with the placental distribution of approximately 3% of the plasma concentration that we report here. To our knowledge, no data are currently available regarding tissue distribution in humans, except that etanercept levels in synovial fluid of three rheumatoid arthritis patients were found to be approximately equal to serum levels.<a href="#cpt1827-bib-0024" class="usa-link" aria-describedby="cpt1827-bib-0024" aria-expanded="false">
<sup>24</sup>
</a> The placental exposure we quantified here amounted to 0.1&nbsp;±&nbsp;0.1&nbsp;µg/g tissue, which is lower than the target serum etanercept trough levels of 2.1&nbsp;µg/mL.<a href="#cpt1827-bib-0025" class="usa-link" aria-describedby="cpt1827-bib-0025" aria-expanded="false">
<sup>25</sup>
</a> Still, from these data it is difficult to conclude whether etanercept tissue levels may be within the therapeutic range. In the literature, only two cases with etanercept measurements in cord blood have been described with intervals between last treatment and delivery of 1–7&nbsp;days.<a href="#cpt1827-bib-0011" class="usa-link" aria-describedby="cpt1827-bib-0011" aria-expanded="false">
<sup>11</sup>
</a>, <a href="#cpt1827-bib-0012" class="usa-link" aria-describedby="cpt1827-bib-0012" aria-expanded="false">
<sup>12</sup>
</a> Cord‐to‐maternal ratios were 0.04&nbsp;in the first case<a href="#cpt1827-bib-0012" class="usa-link" aria-describedby="cpt1827-bib-0012" aria-expanded="false">
<sup>12</sup>
</a> and 0.07&nbsp;in the second case,<a href="#cpt1827-bib-0011" class="usa-link" aria-describedby="cpt1827-bib-0011" aria-expanded="false">
<sup>11</sup>
</a> confirming the limited placental passage observed in the current study.</p>
<p>For small molecule drugs, <em>ex vivo</em> placental transfer correlates well with <em>in vivo</em> cord‐to‐maternal ratios.<a href="#cpt1827-bib-0026" class="usa-link" aria-describedby="cpt1827-bib-0026" aria-expanded="false">
<sup>26</sup>
</a> For antibody‐based biologicals, however, results are more difficult to interpret, as placental transfer of <em>IgG</em>’s is slow compared with small molecules and only minimal transfer is expected to occur after 6&nbsp;hours.<a href="#cpt1827-bib-0027" class="usa-link" aria-describedby="cpt1827-bib-0027" aria-expanded="false">
<sup>27</sup>
</a> Therefore, only the initial phase of IgG transport can be studied via this technique. Additionally, it is not clear yet how <em>in vivo</em> and <em>ex vivo</em> placental drug levels and placenta‐to‐maternal ratios relate to one another. We found that infliximab placenta‐to‐maternal ratios were similar <em>in vivo</em> and <em>ex vivo</em>, which could imply that placental infliximab levels are largely determined by maternal drug concentrations and that infliximab does not accumulate in the placenta. We also observed that <em>in vivo</em> and <em>ex vivo</em> etanercept placenta‐to‐maternal ratios were lower than those of infliximab. This could be explained by differences in affinity for the neonatal Fc‐receptor (FcRn), which is the driving factor for IgG transport across the placental barrier.<a href="#cpt1827-bib-0028" class="usa-link" aria-describedby="cpt1827-bib-0028" aria-expanded="false">
<sup>28</sup>
</a> Also, the FcRn saves IgG molecules from degradation, prolonging their half‐life. Porter <em>et al</em>. determined that infliximab has a ten‐times‐higher affinity for the FcRn than etanercept, which could explain the higher infliximab tissue concentrations.<a href="#cpt1827-bib-0029" class="usa-link" aria-describedby="cpt1827-bib-0029" aria-expanded="false">
<sup>29</sup>
</a> The observed lower placental and maternal concentrations of etanercept could result from spontaneous etanercept degradation in buffer and tissue, but may also be due to enzymatic placental degradation by, for example, metalloproteinases.<a href="#cpt1827-bib-0030" class="usa-link" aria-describedby="cpt1827-bib-0030" aria-expanded="false">
<sup>30</sup>
</a> Although etanercept levels in maternal perfusate declined to 50% and placental tissue concentrations were lower compared with infliximab, we found comparable <em>ex vivo</em> transfer patterns of infliximab and etanercept. However, in two out of five placenta perfusions, etanercept was not detected in the fetal compartment. This could reflect a true absence of etanercept transfer in these placentas, but may also be due to a 10‐fold higher detection limit of the etanercept enzyme‐linked immunosorbent assay compared with the infliximab assay. In future experiments, it may be relevant to perform placenta perfusions with different biologics simultaneously to correct for interindividual differences, provided that they do not interfere with each other's disposition. For reasons of comparison, the concentration of etanercept used was equal to that of infliximab. For etanercept, this is a supratherapeutic concentration, which may explain why etanercept transfer was seen <em>ex vivo</em> in the initial transfer phase, but not <em>in vivo</em> after long‐term exposure to therapeutic levels of etanercept.</p>
<p>Despite the increasing use of therapeutic anti‐TNF antibodies during pregnancy, placental transfer of and exposure to infliximab and etanercept have not been studied in a placenta perfusion model before. Recently, Roy <em>et al</em>. did study placental transfer of the TNF inhibitor adalimumab, a full IgG1 molecule and thus comparable in chemical structure to infliximab, but not etanercept.<a href="#cpt1827-bib-0030" class="usa-link" aria-describedby="cpt1827-bib-0030" aria-expanded="false">
<sup>30</sup>
</a> They found placental transfer rates of adalimumab similar to the values we found for infliximab, with average fetal concentrations after 6&nbsp;hours of 0.5&nbsp;±&nbsp;0.5 and 0.3&nbsp;±&nbsp;0.3&nbsp;µg/mL, respectively. Adalimumab placenta concentrations were not assessed in this study.</p>
<p>When prescribing anti‐TNF therapy to women who wish to conceive, the extent of placental transfer and placental exposure could be taken into consideration. However, further research is needed to better understand the consequences of placental exposure to anti‐TNF therapy. TNF is highly expressed in term placental tissue and is known to play a role in placental development as well as in major placental functions, such as maintenance of the syncytiotrophoblast layer and hormone production.<a href="#cpt1827-bib-0013" class="usa-link" aria-describedby="cpt1827-bib-0013" aria-expanded="false">
<sup>13</sup>
</a> Reducing TNF levels may interfere with placental function, but it may also be important to decrease elevated cytokine levels in autoimmune diseases. Treatment with TNF inhibitors may even improve live birth rates in women with recurrent miscarriage.<a href="#cpt1827-bib-0031" class="usa-link" aria-describedby="cpt1827-bib-0031" aria-expanded="false">
<sup>31</sup>
</a> Furthermore, it would be interesting to investigate whether infliximab and etanercept are bound to TNF in placental tissue and whether differences exist in localization between the two inhibitors. For example, full antibodies such as infliximab, but not etanercept, can bind to monocytes and activated T cells, inducing apoptosis, which may also occur in placental tissue.<a href="#cpt1827-bib-0032" class="usa-link" aria-describedby="cpt1827-bib-0032" aria-expanded="false">
<sup>32</sup>
</a> As etanercept is a TNF receptor Fc‐portion fusion protein, it also binds other ligands of the TNF superfamily, such as lymphotoxin α and ß,<a href="#cpt1827-bib-0032" class="usa-link" aria-describedby="cpt1827-bib-0032" aria-expanded="false">
<sup>32</sup>
</a> of which messenger RNA expression was found in the placenta.<a href="#cpt1827-bib-0033" class="usa-link" aria-describedby="cpt1827-bib-0033" aria-expanded="false">
<sup>33</sup>
</a>
</p>
<p>In conclusion, our data showed significant placental tissue concentrations of infliximab after both <em>in vivo</em> and <em>ex vivo</em> exposure studies. For etanercept, tissue concentrations were much lower, which may be due to different recycling of etanercept by the FcRn. Interestingly, the extent of <em>ex vivo</em> placental transfer during the 6‐hour perfusion period did not differ between these two drugs. Our findings with regard to placental tissue exposure to infliximab and etanercept may be of clinical relevance and warrant further investigation. More specifically, we suggest that future studies should look into the occurrence of placental TNF inhibition and possible consequences thereof.</p></section><section id="cpt1827-sec-0018"><h2 class="pmc_sec_title" data-anchor-id="cpt1827-sec-0018"><a id="cpt1827-sec-0018-anchor" data-anchor-id="cpt1827-sec-0018" class="usa-anchor"></a>Funding</h2>
<p>G.E. was supported by a personal grant from the Radboud University Medical Center.</p></section><section id="cpt1827-sec-0019"><h2 class="pmc_sec_title" data-anchor-id="cpt1827-sec-0019"><a id="cpt1827-sec-0019-anchor" data-anchor-id="cpt1827-sec-0019" class="usa-anchor"></a>Conflict of Interest</h2>
<p>The authors declared no competing interests for this work.</p></section><section id="cpt1827-sec-0020"><h2 class="pmc_sec_title" data-anchor-id="cpt1827-sec-0020"><a id="cpt1827-sec-0020-anchor" data-anchor-id="cpt1827-sec-0020" class="usa-anchor"></a>Author Contributions</h2>
<p>G.A.M.E., J.v.D., A.d.V., N.R., F.G.M.R., and R.G. wrote the manuscript. G.A.M.E., J.v.D., N.R., F.G.M.R., and R.G. designed the research. G.A.M.E., H.v.H., N.I.K., and P.v.d.B. performed the research. G.A.M.E., J.v.D., H.v.H., N.I.K., P.v.d.B., and R.G. analyzed data. A.d.V. contributed new analytical tools.</p></section><section id="sec20"><h2 class="pmc_sec_title" data-anchor-id="sec20"><a id="sec20-anchor" data-anchor-id="sec20" class="usa-anchor"></a>Supporting information</h2>
<section class="sm xbox font-sm" id="cpt1827-sup-0001"><div class="caption p"><p>
<strong>Supplementary Material</strong>
</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7325311/bin/CPT-108-99-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (34.2KB, docx) </sup>
</div></div></section></section><section id="cpt1827-sec-0017" class="ack"><h2 class="pmc_sec_title" data-anchor-id="cpt1827-sec-0017"><a id="cpt1827-sec-0017-anchor" data-anchor-id="cpt1827-sec-0017" class="usa-anchor"></a>Acknowledgments</h2>
<p>We thank the women who provided informed consent for the use of their placentas and blood samples in this study. Also, Gerard Zijderveld and colleagues from the department of Obstetrics and Gynecology at the Radboudumc are kindly acknowledged for obtaining informed consents and providing access to term placentas. Lastly, we thank Jolien Freriksen and Jan Jansen for their major efforts and help improving the placenta perfusion system in our laboratory.</p></section><section id="cpt1827-bibl-0001" class="ref-list"><h2 class="pmc_sec_title" data-anchor-id="cpt1827-bibl-0001"><a id="cpt1827-bibl-0001-anchor" data-anchor-id="cpt1827-bibl-0001" class="usa-anchor"></a>References</h2>
<section id="cpt1827-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="cpt1827-bib-0001">
<span class="label">1.</span><cite>

de Jong, P.H.P.
 &amp; 
Dolhain, R.J.E.M.

Fertility, pregnancy, and lactation in rheumatoid arthritis. Rheum. Dis. Clin. North Am.
43, 227–237 (2017).</cite> [<a href="https://doi.org/10.1016/j.rdc.2016.12.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28390565/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rheum.%20Dis.%20Clin.%20North%20Am.&amp;title=Fertility,%20pregnancy,%20and%20lactation%20in%20rheumatoid%20arthritis&amp;author=P.H.P.%20de%20Jong&amp;author=R.J.E.M.%20Dolhain&amp;volume=43&amp;publication_year=2017&amp;pages=227-237&amp;pmid=28390565&amp;doi=10.1016/j.rdc.2016.12.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0002">
<span class="label">2.</span><cite>

Cornish, J.

<em>et al</em>
A meta‐analysis on the influence of inflammatory bowel disease on pregnancy. Gut
56, 830–837 (2007).</cite> [<a href="https://doi.org/10.1136/gut.2006.108324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1954859/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17185356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=A%20meta%E2%80%90analysis%20on%20the%20influence%20of%20inflammatory%20bowel%20disease%20on%20pregnancy&amp;author=J.%20Cornish&amp;volume=56&amp;publication_year=2007&amp;pages=830-837&amp;pmid=17185356&amp;doi=10.1136/gut.2006.108324&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0003">
<span class="label">3.</span><cite>

Bröms, G.
, 
Granath, F.
, 
Linder, M.
, 
Stephansson, O.
, 
Elmberg, M.
 &amp; 
Kieler, H.

Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure. Inflamm. Bowel Dis.
20, 1091–1098 (2014).</cite> [<a href="https://doi.org/10.1097/MIB.0000000000000060" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24810137/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm.%20Bowel%20Dis.&amp;title=Birth%20outcomes%20in%20women%20with%20inflammatory%20bowel%20disease:%20effects%20of%20disease%20activity%20and%20drug%20exposure&amp;author=G.%20Br%C3%B6ms&amp;author=F.%20Granath&amp;author=M.%20Linder&amp;author=O.%20Stephansson&amp;author=M.%20Elmberg&amp;volume=20&amp;publication_year=2014&amp;pages=1091-1098&amp;pmid=24810137&amp;doi=10.1097/MIB.0000000000000060&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0004">
<span class="label">4.</span><cite>

McConnell, R.A.
 &amp; 
Mahadevan, U.

Use of immunomodulators and biologics before, during, and after pregnancy. Inflamm. Bowel. Dis.
22, 213–223 (2016).</cite> [<a href="https://doi.org/10.1097/MIB.0000000000000596" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26444103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm.%20Bowel.%20Dis.&amp;title=Use%20of%20immunomodulators%20and%20biologics%20before,%20during,%20and%20after%20pregnancy&amp;author=R.A.%20McConnell&amp;author=U.%20Mahadevan&amp;volume=22&amp;publication_year=2016&amp;pages=213-223&amp;pmid=26444103&amp;doi=10.1097/MIB.0000000000000596&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0005">
<span class="label">5.</span><cite>

Gotestam Skorpen, C.

<em>et al</em>
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann. Rheum. Dis.
75, 795–810 (2016).</cite> [<a href="https://doi.org/10.1136/annrheumdis-2015-208840" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26888948/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Rheum.%20Dis.&amp;title=The%20EULAR%20points%20to%20consider%20for%20use%20of%20antirheumatic%20drugs%20before%20pregnancy,%20and%20during%20pregnancy%20and%20lactation&amp;author=C.%20Gotestam%20Skorpen&amp;volume=75&amp;publication_year=2016&amp;pages=795-810&amp;pmid=26888948&amp;doi=10.1136/annrheumdis-2015-208840&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0006">
<span class="label">6.</span><cite>

Narula, N.
, 
Al‐Dabbagh, R.
, 
Dhillon, A.
, 
Sands, B.E.
 &amp; 
Marshall, J.K.

Anti‐TNFalpha therapies are safe during pregnancy in women with inflammatory bowel disease: a systematic review and meta‐analysis. Inflamm. Bowel Dis.
20, 1862–1869 (2014).</cite> [<a href="https://doi.org/10.1097/MIB.0000000000000092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24983985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm.%20Bowel%20Dis.&amp;title=Anti%E2%80%90TNFalpha%20therapies%20are%20safe%20during%20pregnancy%20in%20women%20with%20inflammatory%20bowel%20disease:%20a%20systematic%20review%20and%20meta%E2%80%90analysis&amp;author=N.%20Narula&amp;author=R.%20Al%E2%80%90Dabbagh&amp;author=A.%20Dhillon&amp;author=B.E.%20Sands&amp;author=J.K.%20Marshall&amp;volume=20&amp;publication_year=2014&amp;pages=1862-1869&amp;pmid=24983985&amp;doi=10.1097/MIB.0000000000000092&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0007">
<span class="label">7.</span><cite>

Wieringa, J.W.
, 
Driessen, G.J.
 &amp; 
Van Der Woude, C.J.

Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system. Expert Rev. Gastroenterol. Hepatol.
12, 811–818 (2018).</cite> [<a href="https://doi.org/10.1080/17474124.2018.1496820" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29972674/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Rev.%20Gastroenterol.%20Hepatol.&amp;title=Pregnant%20women%20with%20inflammatory%20bowel%20disease:%20the%20effects%20of%20biologicals%20on%20pregnancy,%20outcome%20of%20infants,%20and%20the%20developing%20immune%20system&amp;author=J.W.%20Wieringa&amp;author=G.J.%20Driessen&amp;author=C.J.%20Van%20Der%20Woude&amp;volume=12&amp;publication_year=2018&amp;pages=811-818&amp;pmid=29972674&amp;doi=10.1080/17474124.2018.1496820&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0008">
<span class="label">8.</span><cite>

Weber‐Schoendorfer, C.

<em>et al</em>
Pregnancy outcome after TNF‐alpha inhibitor therapy during the first trimester: a prospective multicentre cohort study. Br. J. Clin. Pharmacol.
80, 727–739 (2015).</cite> [<a href="https://doi.org/10.1111/bcp.12642" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4594709/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25808588/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Clin.%20Pharmacol.&amp;title=Pregnancy%20outcome%20after%20TNF%E2%80%90alpha%20inhibitor%20therapy%20during%20the%20first%20trimester:%20a%20prospective%20multicentre%20cohort%20study&amp;author=C.%20Weber%E2%80%90Schoendorfer&amp;volume=80&amp;publication_year=2015&amp;pages=727-739&amp;pmid=25808588&amp;doi=10.1111/bcp.12642&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0009">
<span class="label">9.</span><cite>

Hyrich, K.L.
 &amp; 
Verstappen, S.M.M.

Biologic therapies and pregnancy: the story so far. Rheumatology (Oxford)
53, 1377–1385 (2014).</cite> [<a href="https://doi.org/10.1093/rheumatology/ket409" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24352337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rheumatology%20(Oxford)&amp;title=Biologic%20therapies%20and%20pregnancy:%20the%20story%20so%20far&amp;author=K.L.%20Hyrich&amp;author=S.M.M.%20Verstappen&amp;volume=53&amp;publication_year=2014&amp;pages=1377-1385&amp;pmid=24352337&amp;doi=10.1093/rheumatology/ket409&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0010">
<span class="label">10.</span><cite>

Kanis, S.L.
, 
de Lima‐Karagiannis, A.
, 
van der Ent, C.
, 
Rizopoulos, D.
 &amp; 
van der Woude, C.J.

Anti‐TNF levels in cord blood at birth are associated with anti‐TNF type. J. Crohns Colitis
12, 939–947 (2018).</cite> [<a href="https://doi.org/10.1093/ecco-jcc/jjy058" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29771301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Crohns%20Colitis&amp;title=Anti%E2%80%90TNF%20levels%20in%20cord%20blood%20at%20birth%20are%20associated%20with%20anti%E2%80%90TNF%20type&amp;author=S.L.%20Kanis&amp;author=A.%20de%20Lima%E2%80%90Karagiannis&amp;author=C.%20van%20der%20Ent&amp;author=D.%20Rizopoulos&amp;author=C.J.%20van%20der%20Woude&amp;volume=12&amp;publication_year=2018&amp;pages=939-947&amp;pmid=29771301&amp;doi=10.1093/ecco-jcc/jjy058&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0011">
<span class="label">11.</span><cite>

Berthelsen, B.G.
, 
Fjeldsøe‐Nielsen, H.
, 
Nielsen, C.T.
 &amp; 
Hellmuth, E.

Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding. Rheumatology (Oxford)
49, 2225–2227 (2010).</cite> [<a href="https://doi.org/10.1093/rheumatology/keq185" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20581374/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rheumatology%20(Oxford)&amp;title=Etanercept%20concentrations%20in%20maternal%20serum,%20umbilical%20cord%20serum,%20breast%20milk%20and%20child%20serum%20during%20breastfeeding&amp;author=B.G.%20Berthelsen&amp;author=H.%20Fjelds%C3%B8e%E2%80%90Nielsen&amp;author=C.T.%20Nielsen&amp;author=E.%20Hellmuth&amp;volume=49&amp;publication_year=2010&amp;pages=2225-2227&amp;pmid=20581374&amp;doi=10.1093/rheumatology/keq185&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0012">
<span class="label">12.</span><cite>

Murashima, A.
, 
Watanabe, N.
, 
Ozawa, N.
, 
Saito, H.
 &amp; 
Yamaguchi, K.

Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum. Ann. Rheum. Dis.
68, 1793–1794 (2009).</cite> [<a href="https://doi.org/10.1136/ard.2008.105924" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19822717/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Rheum.%20Dis.&amp;title=Etanercept%20during%20pregnancy%20and%20lactation%20in%20a%20patient%20with%20rheumatoid%20arthritis:%20drug%20levels%20in%20maternal%20serum,%20cord%20blood,%20breast%20milk%20and%20the%20infant's%20serum&amp;author=A.%20Murashima&amp;author=N.%20Watanabe&amp;author=N.%20Ozawa&amp;author=H.%20Saito&amp;author=K.%20Yamaguchi&amp;volume=68&amp;publication_year=2009&amp;pages=1793-1794&amp;pmid=19822717&amp;doi=10.1136/ard.2008.105924&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0013">
<span class="label">13.</span><cite>

Haider, S.
 &amp; 
Knöfler, M.

Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta
30, 111–123 (2009).</cite> [<a href="https://doi.org/10.1016/j.placenta.2008.10.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2974215/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19027157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Placenta&amp;title=Human%20tumour%20necrosis%20factor:%20physiological%20and%20pathological%20roles%20in%20placenta%20and%20endometrium&amp;author=S.%20Haider&amp;author=M.%20Kn%C3%B6fler&amp;volume=30&amp;publication_year=2009&amp;pages=111-123&amp;pmid=19027157&amp;doi=10.1016/j.placenta.2008.10.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0014">
<span class="label">14.</span><cite>

Mathiesen, L.

<em>et al</em>
Quality assessment of a placental perfusion protocol. Reprod. Toxicol.
30, 138–146 (2010).</cite> [<a href="https://doi.org/10.1016/j.reprotox.2010.01.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20096346/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Reprod.%20Toxicol.&amp;title=Quality%20assessment%20of%20a%20placental%20perfusion%20protocol&amp;author=L.%20Mathiesen&amp;volume=30&amp;publication_year=2010&amp;pages=138-146&amp;pmid=20096346&amp;doi=10.1016/j.reprotox.2010.01.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0015">
<span class="label">15.</span><cite>

Kneepkens, E.L.

<em>et al</em>
Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow‐up. Ann. Rheum. Dis.
74, 1825–1829 (2015).</cite> [<a href="https://doi.org/10.1136/annrheumdis-2014-205213" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24812290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Rheum.%20Dis.&amp;title=Lower%20etanercept%20levels%20are%20associated%20with%20high%20disease%20activity%20in%20ankylosing%20spondylitis%20patients%20at%2024%20weeks%20of%20follow%E2%80%90up&amp;author=E.L.%20Kneepkens&amp;volume=74&amp;publication_year=2015&amp;pages=1825-1829&amp;pmid=24812290&amp;doi=10.1136/annrheumdis-2014-205213&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0016">
<span class="label">16.</span><cite>

Wolbink, G.J.

<em>et al</em>
Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis. Ann. Rheum. Dis.
64, 704–707 (2005).</cite> [<a href="https://doi.org/10.1136/ard.2004.030452" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1755482/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15485995/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Rheum.%20Dis.&amp;title=Relationship%20between%20serum%20trough%20infliximab%20levels,%20pretreatment%20C%20reactive%20protein%20levels,%20and%20clinical%20response%20to%20infliximab%20treatment%20in%20patients%20with%20rheumatoid%20arthritis&amp;author=G.J.%20Wolbink&amp;volume=64&amp;publication_year=2005&amp;pages=704-707&amp;pmid=15485995&amp;doi=10.1136/ard.2004.030452&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0017">
<span class="label">17.</span><cite>

van Bezooijen, J.S.

<em>et al</em>
Intrapatient variability in the pharmacokinetics of etanercept maintenance treatment. Ther. Drug Monit.
39, 333–338 (2017).</cite> [<a href="https://doi.org/10.1097/FTD.0000000000000384" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28691952/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ther.%20Drug%20Monit.&amp;title=Intrapatient%20variability%20in%20the%20pharmacokinetics%20of%20etanercept%20maintenance%20treatment&amp;author=J.S.%20van%20Bezooijen&amp;volume=39&amp;publication_year=2017&amp;pages=333-338&amp;pmid=28691952&amp;doi=10.1097/FTD.0000000000000384&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0018">
<span class="label">18.</span><cite>

Barker, G.
, 
Boyd, R.D.
, 
D'Souza, S.W.
, 
Donnai, P.
, 
Fox, H.
 &amp; 
Sibley, C.P.

Placental water content and distribution. Placenta
15, 47–56 (1994).</cite> [<a href="https://doi.org/10.1016/s0143-4004(05)80235-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8208669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Placenta&amp;title=Placental%20water%20content%20and%20distribution&amp;author=G.%20Barker&amp;author=R.D.%20Boyd&amp;author=S.W.%20D'Souza&amp;author=P.%20Donnai&amp;author=H.%20Fox&amp;volume=15&amp;publication_year=1994&amp;pages=47-56&amp;pmid=8208669&amp;doi=10.1016/s0143-4004(05)80235-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0019">
<span class="label">19.</span><cite>

Chiossi, G.

<em>et al</em>
Reference intervals for hemoglobin and hematocrit in a low‐risk pregnancy cohort: implications of racial differences. J. Matern. Fetal Neonatal. Med. 32, 2897–2904, (2019).</cite> [<a href="https://doi.org/10.1080/14767058.2018.1452905" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29534635/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Matern.%20Fetal%20Neonatal.%20Med.&amp;title=Reference%20intervals%20for%20hemoglobin%20and%20hematocrit%20in%20a%20low%E2%80%90risk%20pregnancy%20cohort:%20implications%20of%20racial%20differences&amp;author=G.%20Chiossi&amp;publication_year=2019&amp;pages=2897-2904&amp;pmid=29534635&amp;doi=10.1080/14767058.2018.1452905&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0020">
<span class="label">20.</span><cite>

Glasser, L.
, 
Sutton, N.
, 
Schmeling, M.
 &amp; 
Machan, J.T.

A comprehensive study of umbilical cord blood cell developmental changes and reference ranges by gestation, gender and mode of delivery. J. Perinatol.
35, 469–475 (2015).</cite> [<a href="https://doi.org/10.1038/jp.2014.241" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25634517/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Perinatol.&amp;title=A%20comprehensive%20study%20of%20umbilical%20cord%20blood%20cell%20developmental%20changes%20and%20reference%20ranges%20by%20gestation,%20gender%20and%20mode%20of%20delivery&amp;author=L.%20Glasser&amp;author=N.%20Sutton&amp;author=M.%20Schmeling&amp;author=J.T.%20Machan&amp;volume=35&amp;publication_year=2015&amp;pages=469-475&amp;pmid=25634517&amp;doi=10.1038/jp.2014.241&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0021">
<span class="label">21.</span><cite>

Yoshihara, T.

<em>et al</em>
Tissue drug concentrations of anti‐tumor necrosis factor agents are associated with the long‐term outcome of patients with Crohn's disease. Inflamm. Bowel Dis.
23, 2172–2179 (2017).</cite> [<a href="https://doi.org/10.1097/MIB.0000000000001260" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28945638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm.%20Bowel%20Dis.&amp;title=Tissue%20drug%20concentrations%20of%20anti%E2%80%90tumor%20necrosis%20factor%20agents%20are%20associated%20with%20the%20long%E2%80%90term%20outcome%20of%20patients%20with%20Crohn's%20disease&amp;author=T.%20Yoshihara&amp;volume=23&amp;publication_year=2017&amp;pages=2172-2179&amp;pmid=28945638&amp;doi=10.1097/MIB.0000000000001260&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0022">
<span class="label">22.</span><cite>

Park, W.

<em>et al</em>
A randomised, double‐blind, multicentre, parallel‐group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT‐P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study. Ann. Rheum. Dis.
72, 1605–1612 (2013).</cite> [<a href="https://doi.org/10.1136/annrheumdis-2012-203091" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3786643/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23687259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Rheum.%20Dis.&amp;title=A%20randomised,%20double%E2%80%90blind,%20multicentre,%20parallel%E2%80%90group,%20prospective%20study%20comparing%20the%20pharmacokinetics,%20safety,%20and%20efficacy%20of%20CT%E2%80%90P13%20and%20innovator%20infliximab%20in%20patients%20with%20ankylosing%20spondylitis:%20the%20PLANETAS%20study&amp;author=W.%20Park&amp;volume=72&amp;publication_year=2013&amp;pages=1605-1612&amp;pmid=23687259&amp;doi=10.1136/annrheumdis-2012-203091&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0023">
<span class="label">23.</span><cite>

Chen, X.
, 
DuBois, D.C.
, 
Almon, R.R.
 &amp; 
Jusko, W.J.

Biodistribution of etanercept to tissues and sites of inflammation in arthritic rats. Drug Metab. Dispos.
43, 898–907 (2015).</cite> [<a href="https://doi.org/10.1124/dmd.114.062901" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4429683/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25834031/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Metab.%20Dispos.&amp;title=Biodistribution%20of%20etanercept%20to%20tissues%20and%20sites%20of%20inflammation%20in%20arthritic%20rats&amp;author=X.%20Chen&amp;author=D.C.%20DuBois&amp;author=R.R.%20Almon&amp;author=W.J.%20Jusko&amp;volume=43&amp;publication_year=2015&amp;pages=898-907&amp;pmid=25834031&amp;doi=10.1124/dmd.114.062901&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0024">
<span class="label">24.</span><cite>

Zhou, H.

Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein. J. Clin. Pharmacol.
45, 490–497 (2005).</cite> [<a href="https://doi.org/10.1177/0091270004273321" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15831771/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Pharmacol.&amp;title=Clinical%20pharmacokinetics%20of%20etanercept:%20a%20fully%20humanized%20soluble%20recombinant%20tumor%20necrosis%20factor%20receptor%20fusion%20protein&amp;author=H.%20Zhou&amp;volume=45&amp;publication_year=2005&amp;pages=490-497&amp;pmid=15831771&amp;doi=10.1177/0091270004273321&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0025">
<span class="label">25.</span><cite>

Sanchez‐Hernandez, J.G.
, 
Rebollo, N.
, 
Munoz, F.
, 
Martin‐Suarez, A.
 &amp; 
Calvo, M.V.

Therapeutic drug monitoring of tumour necrosis factor inhibitors in the management of chronic inflammatory diseases. Ann. Clin. Biochem.
56, 28–41 (2019).</cite> [<a href="https://doi.org/10.1177/0004563218782286" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29807436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Clin.%20Biochem.&amp;title=Therapeutic%20drug%20monitoring%20of%20tumour%20necrosis%20factor%20inhibitors%20in%20the%20management%20of%20chronic%20inflammatory%20diseases&amp;author=J.G.%20Sanchez%E2%80%90Hernandez&amp;author=N.%20Rebollo&amp;author=F.%20Munoz&amp;author=A.%20Martin%E2%80%90Suarez&amp;author=M.V.%20Calvo&amp;volume=56&amp;publication_year=2019&amp;pages=28-41&amp;pmid=29807436&amp;doi=10.1177/0004563218782286&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0026">
<span class="label">26.</span><cite>

Hutson, J.R.
, 
Garcia‐Bournissen, F.
, 
Davis, A.
 &amp; 
Koren, G.

The human placental perfusion model: a systematic review and development of a model to predict <em>in vivo</em> transfer of therapeutic drugs. Clin. Pharmacol. Ther.
90, 67–76 (2011).</cite> [<a href="https://doi.org/10.1038/clpt.2011.66" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21562489/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Pharmacol.%20Ther.&amp;title=The%20human%20placental%20perfusion%20model:%20a%20systematic%20review%20and%20development%20of%20a%20model%20to%20predict%20in%20vivo%20transfer%20of%20therapeutic%20drugs&amp;author=J.R.%20Hutson&amp;author=F.%20Garcia%E2%80%90Bournissen&amp;author=A.%20Davis&amp;author=G.%20Koren&amp;volume=90&amp;publication_year=2011&amp;pages=67-76&amp;pmid=21562489&amp;doi=10.1038/clpt.2011.66&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0027">
<span class="label">27.</span><cite>

Mathiesen, L.

<em>et al</em>
Maternofetal transplacental transport of recombinant IgG antibodies lacking effector functions. Blood
122, 1174–1181 (2013).</cite> [<a href="https://doi.org/10.1182/blood-2012-12-473843" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23843496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Maternofetal%20transplacental%20transport%20of%20recombinant%20IgG%20antibodies%20lacking%20effector%20functions&amp;author=L.%20Mathiesen&amp;volume=122&amp;publication_year=2013&amp;pages=1174-1181&amp;pmid=23843496&amp;doi=10.1182/blood-2012-12-473843&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0028">
<span class="label">28.</span><cite>

Roopenian, D.C.
 &amp; 
Akilesh, S.

FcRn: the neonatal Fc receptor comes of age. Nat. Rev. Immunol.
7, 715–725 (2007).</cite> [<a href="https://doi.org/10.1038/nri2155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17703228/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Immunol.&amp;title=FcRn:%20the%20neonatal%20Fc%20receptor%20comes%20of%20age&amp;author=D.C.%20Roopenian&amp;author=S.%20Akilesh&amp;volume=7&amp;publication_year=2007&amp;pages=715-725&amp;pmid=17703228&amp;doi=10.1038/nri2155&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0029">
<span class="label">29.</span><cite>

Porter, C.

<em>et al</em>
Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn‐mediated <em>in vitro</em> transcytosis and <em>ex vivo</em> human placental transfer. J. Reprod. Immunol.
116, 7–12 (2016).</cite> [<a href="https://doi.org/10.1016/j.jri.2016.04.284" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27123565/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Reprod.%20Immunol.&amp;title=Certolizumab%20pegol%20does%20not%20bind%20the%20neonatal%20Fc%20receptor%20(FcRn):%20Consequences%20for%20FcRn%E2%80%90mediated%20in%20vitro%20transcytosis%20and%20ex%20vivo%20human%20placental%20transfer&amp;author=C.%20Porter&amp;volume=116&amp;publication_year=2016&amp;pages=7-12&amp;pmid=27123565&amp;doi=10.1016/j.jri.2016.04.284&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0030">
<span class="label">30.</span><cite>

Biancheri, P.

<em>et al</em>
Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease. Gastroenterology
149, 1564–1574.e3 (2015).</cite> [<a href="https://doi.org/10.1053/j.gastro.2015.07.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26170138/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Proteolytic%20cleavage%20and%20loss%20of%20function%20of%20biologic%20agents%20that%20neutralize%20tumor%20necrosis%20factor%20in%20the%20mucosa%20of%20patients%20with%20inflammatory%20bowel%20disease&amp;author=P.%20Biancheri&amp;volume=149&amp;publication_year=2015&amp;pages=1564-1574&amp;pmid=26170138&amp;doi=10.1053/j.gastro.2015.07.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0031">
<span class="label">31.</span><cite>

Winger, E.E.
 &amp; 
Reed, J.L.

Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am. J. Reprod. Immunol.
60, 8–16 (2008).</cite> [<a href="https://doi.org/10.1111/j.1600-0897.2008.00585.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18422811/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Reprod.%20Immunol.&amp;title=Treatment%20with%20tumor%20necrosis%20factor%20inhibitors%20and%20intravenous%20immunoglobulin%20improves%20live%20birth%20rates%20in%20women%20with%20recurrent%20spontaneous%20abortion&amp;author=E.E.%20Winger&amp;author=J.L.%20Reed&amp;volume=60&amp;publication_year=2008&amp;pages=8-16&amp;pmid=18422811&amp;doi=10.1111/j.1600-0897.2008.00585.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0032">
<span class="label">32.</span><cite>

Mitoma, H.
, 
Horiuchi, T.
, 
Tsukamoto, H.
 &amp; 
Ueda, N.

Molecular mechanisms of action of anti‐TNF‐alpha agents – comparison among therapeutic TNF‐alpha antagonists. Cytokine
101, 56–63 (2018).</cite> [<a href="https://doi.org/10.1016/j.cyto.2016.08.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27567553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cytokine&amp;title=Molecular%20mechanisms%20of%20action%20of%20anti%E2%80%90TNF%E2%80%90alpha%20agents%20%E2%80%93%20comparison%20among%20therapeutic%20TNF%E2%80%90alpha%20antagonists&amp;author=H.%20Mitoma&amp;author=T.%20Horiuchi&amp;author=H.%20Tsukamoto&amp;author=N.%20Ueda&amp;volume=101&amp;publication_year=2018&amp;pages=56-63&amp;pmid=27567553&amp;doi=10.1016/j.cyto.2016.08.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cpt1827-bib-0033">
<span class="label">33.</span><cite>

Phillips, T.A.
, 
Ni, J.
 &amp; 
Hunt, J.S.

Death‐inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines. Placenta
22, 663–672 (2001).</cite> [<a href="https://doi.org/10.1053/plac.2001.0703" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11597186/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Placenta&amp;title=Death%E2%80%90inducing%20tumour%20necrosis%20factor%20(TNF)%20superfamily%20ligands%20and%20receptors%20are%20transcribed%20in%20human%20placentae,%20cytotrophoblasts,%20placental%20macrophages%20and%20placental%20cell%20lines&amp;author=T.A.%20Phillips&amp;author=J.%20Ni&amp;author=J.S.%20Hunt&amp;volume=22&amp;publication_year=2001&amp;pages=663-672&amp;pmid=11597186&amp;doi=10.1053/plac.2001.0703&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title" data-anchor-id="_ad93_"><a id="_ad93_-anchor" data-anchor-id="_ad93_" class="usa-anchor"></a>Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>
<strong>Supplementary Material</strong>
</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7325311/bin/CPT-108-99-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (34.2KB, docx) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Clinical Pharmacology and Therapeutics are provided here courtesy of <strong>Wiley and American Society for Clinical Pharmacology and Therapeutics</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close">
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a href="https://doi.org/10.1002/cpt.1827" class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1" target="_blank" rel="noreferrer noopener" data-ga-category="actions" data-ga-action="click" data-ga-label="publisher_link_desktop">
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden="">
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a href="pdf/CPT-108-99.pdf" class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1" data-ga-category="actions" data-ga-action="click" data-ga-label="pdf_download_desktop">
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden="">
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (397.3&nbsp;KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1" aria-label="Open dialog with citation text in different styles" data-ga-category="actions" data-ga-action="open" data-ga-label="cite_desktop" data-all-citations-url="/resources/citations/7325311/" data-citation-style="nlm" data-download-format-link="/resources/citations/7325311/export/">
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden="">
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty" aria-label="Save article in MyNCBI collections." data-ga-category="actions" data-ga-action="click" data-ga-label="collections_button_desktop" data-collections-open-dialog-enabled="false" data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC7325311%2F%23open-collections-dialog" data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden="">
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden="">
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button type="button" class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none" aria-label="Show article permalink" aria-expanded="false" aria-haspopup="true" data-ga-category="actions" data-ga-action="open" data-ga-label="permalink_desktop">
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden="">
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden="">
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC7325311/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link" aria-expanded="false">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC7325311/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple="">
                    <h3 class="usa-accordion__heading">
                        <button type="button" class="usa-accordion__button" aria-expanded="false" aria-controls="resources-similar-articles" data-ga-category="resources_accordion" data-ga-action="open_similar_articles" data-ga-label="/articles/PMC7325311/" data-action-open="open_similar_articles" data-action-close="close_similar_articles">
                            Similar articles
                        </button>
                    </h3>
                    <div id="resources-similar-articles" class="usa-accordion__content usa-prose" data-source-url="/resources/similar-article-links/32153014/" hidden="">
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button type="button" class="usa-accordion__button" aria-expanded="false" aria-controls="resources-cited-by-other-articles" data-ga-category="resources_accordion" data-ga-action="open_cited_by" data-ga-label="/articles/PMC7325311/" data-action-open="open_cited_by" data-action-close="close_cited_by">
                             Cited by other articles
                        </button>
                    </h3>
                    <div id="resources-cited-by-other-articles" class="usa-accordion__content usa-prose" data-source-url="/resources/cited-by-links/32153014/" hidden="">
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button type="button" class="usa-accordion__button" aria-expanded="false" aria-controls="resources-links-to-ncbi-databases" data-ga-category="resources_accordion" data-ga-action="open_NCBI_links" data-ga-label="/articles/PMC7325311/" data-action-open="open_NCBI_links" data-action-close="close_NCBI_link">
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div id="resources-links-to-ncbi-databases" class="usa-accordion__content usa-prose" data-source-url="/resources/db-links/7325311/" hidden="">
                        </div>
                    
                    
                </div>
            
        </section>


        <section class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4" data-title-text="On this page" data-title-heading-level="h2" data-scroll-offset="0" data-root-margin="-10% 0px -80% 0px" data-main-content-selector="main" data-threshold="1"><nav aria-label="On this page" class="usa-in-page-nav__nav"><h2 class="usa-in-page-nav__heading" tabindex="0">On this page</h2><ul class="usa-in-page-nav__list"><li class="usa-in-page-nav__item"><a data-anchor-id="cpt1827-abs-0001" href="#cpt1827-abs-0001" class="usa-in-page-nav__link" data-ga-category="article_side_nav" data-ga-action="click" data-ga-label="Abstract">Abstract</a></li><li class="usa-in-page-nav__item"><a data-anchor-id="cpt1827-sec-0002" href="#cpt1827-sec-0002" class="usa-in-page-nav__link" data-ga-category="article_side_nav" data-ga-action="click" data-ga-label="Methods">Methods</a></li><li class="usa-in-page-nav__item"><a data-anchor-id="cpt1827-sec-0009" href="#cpt1827-sec-0009" class="usa-in-page-nav__link" data-ga-category="article_side_nav" data-ga-action="click" data-ga-label="Results">Results</a></li><li class="usa-in-page-nav__item"><a data-anchor-id="cpt1827-sec-0016" href="#cpt1827-sec-0016" class="usa-in-page-nav__link" data-ga-category="article_side_nav" data-ga-action="click" data-ga-label="Discussion">Discussion</a></li><li class="usa-in-page-nav__item"><a data-anchor-id="cpt1827-sec-0018" href="#cpt1827-sec-0018" class="usa-in-page-nav__link" data-ga-category="article_side_nav" data-ga-action="click" data-ga-label="Funding">Funding</a></li><li class="usa-in-page-nav__item"><a data-anchor-id="cpt1827-sec-0019" href="#cpt1827-sec-0019" class="usa-in-page-nav__link" data-ga-category="article_side_nav" data-ga-action="click" data-ga-label="Conflict of Interest">Conflict of Interest</a></li><li class="usa-in-page-nav__item"><a data-anchor-id="cpt1827-sec-0020" href="#cpt1827-sec-0020" class="usa-in-page-nav__link" data-ga-category="article_side_nav" data-ga-action="click" data-ga-label="Author Contributions">Author Contributions</a></li><li class="usa-in-page-nav__item"><a data-anchor-id="sec20" href="#sec20" class="usa-in-page-nav__link" data-ga-category="article_side_nav" data-ga-action="click" data-ga-label="Supporting information">Supporting information</a></li><li class="usa-in-page-nav__item"><a data-anchor-id="cpt1827-sec-0017" href="#cpt1827-sec-0017" class="usa-in-page-nav__link" data-ga-category="article_side_nav" data-ga-action="click" data-ga-label="Acknowledgments">Acknowledgments</a></li><li class="usa-in-page-nav__item"><a data-anchor-id="cpt1827-bibl-0001" href="#cpt1827-bibl-0001" class="usa-in-page-nav__link" data-ga-category="article_side_nav" data-ga-action="click" data-ga-label="References">References</a></li><li class="usa-in-page-nav__item"><a data-anchor-id="_ad93_" href="#_ad93_" class="usa-in-page-nav__link" data-ga-category="article_side_nav" data-ga-action="click" data-ga-label="Associated Data">Associated Data</a></li></ul></nav></section>
    </section>
</div>


        

<div class="overlay citation-dialog-overlay" role="dialog" aria-label="Citation Dialog">
    <div class="dialog citation-dialog" aria-hidden="true" role="document">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto" tabindex="1" data-pinger-ignore="true">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus" data-ga-category="save_share" data-ga-action="cite" data-ga-label="copy" tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a href="#" role="button" class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button" data-ga-category="save_share" data-ga-action="cite" data-ga-label="download" title="Download a file for external citation management software" tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4">
    
      <option data-style-url-name="ama" value="AMA">
        AMA
      </option>
    
      <option data-style-url-name="apa" value="APA">
        APA
      </option>
    
      <option data-style-url-name="mla" value="MLA">
        MLA
      </option>
    
      <option data-style-url-name="nlm" value="NLM" selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
<div class="dots-loading-indicator citation-loading-indicator">
        <div class="dot dot-1"></div>
        <div class="dot dot-2"></div>
        <div class="dot dot-3"></div>
      </div></div>
    </div>
</div>

        <div class="overlay collections-dialog-overlay" role="dialog">
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true" role="document">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form" class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors" data-existing-collections-url="/list-existing-collections/" data-add-to-existing-collection-url="/add-to-existing-collection/" data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/" data-myncbi-max-collection-name-length="100" data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="mKOvfuy3VIWE6bkSWI4te05iKhmSJ0aCoJDm7jno9bzFqGwNsdf8oB36m3zBPbcC">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio" id="collections-action-dialog-new" class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0" name="collections" value="new" data-ga-category="collections_button" data-ga-action="click" data-ga-label="collections_radio_new">
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio" id="collections-action-dialog-existing" class="usa-radio__input usa-radio__input--tile collections-existing" name="collections" value="existing" checked="true" data-ga-category="collections_button" data-ga-action="click" data-ga-label="collections_radio_existing">
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input type="text" name="add-to-new-collection" id="collections-action-dialog-add-to-new" class="usa-input collections-action-add-to-new" pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/" maxlength="" data-ga-category="collections_button" data-ga-action="create_collection" data-ga-label="non_favorties_collection" required="">
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing" class="usa-select collections-action-add-to-existing" data-ga-category="collections_button" data-ga-action="select_collection" data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit" type="submit" data-loading-label="Adding..." data-pinger-ignore="" data-ga-category="collections_button" data-ga-action="click" data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel" aria-label="Close 'Add to Collections' panel" ref="linksrc=close_collections_panel" data-ga-category="collections_button" data-ga-action="click" data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background ">
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener">
                        <svg width="40" height="40" viewBox="0 0 40 40" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener">
                        <svg width="16" height="29" focusable="false" aria-hidden="true" viewBox="0 0 16 29" fill="none" xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener">
                        <svg width="25" height="23" viewBox="0 0 26 24" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener">
                        <svg width="28" height="27" viewBox="0 0 28 28" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener">
                        <svg width="26" height="26" viewBox="0 0 27 27" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer" class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container" data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href="https://twitter.com/nlm_nih" class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32" height="32" viewBox="0 0 40 40" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href="https://www.facebook.com/nationallibraryofmedicine" class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13" height="24" viewBox="0 0 13 24" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href="https://www.youtube.com/user/NLMNIH" class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21" height="15" viewBox="0 0 21 15" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z" fill="white"></path>
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external" href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323" rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br> 8600 Rockville Pike<br> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link">
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link">
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target="_blank">
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/?pagename=cloudpmc-viewer%3Apmc%3Aarticle%3Ajournal" class="usa-link  usa-link--alt ncbi-footer__link" data-pinger-pagename-param="true">
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link">
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link">
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link">
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link">
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target="_blank">
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target="_blank">
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script><div id="ZN_dikYWqsjiUWN0Q5"></div>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-B7-tgZZA.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-BLbQGH8u.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-DKf1UY8S.js"></script>
    
    

    

<div class="fake-body-scroll"></div><div class="fake-body-scroll"></div><script id="_fed_an_ua_tag" text="" charset="" type="text/javascript" src="https://dap.digitalgov.gov/Universal-Federated-Analytics-Min.js?agency=HHS&amp;subagency=NCBI%20-%20ncbi.nlm.nih.gov&amp;sitetopic=NCBI%20Pinger%200.39.3&amp;siteplatform=NCBI%20Pinger%200.39.3"></script><script type="text/javascript" src="https://zndikYWqsjiUWN0Q5-nlmenterprise.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_dikYWqsjiUWN0Q5"></script><script src="https://siteintercept.qualtrics.com/dxjsmodule/CoreModule.js?Q_CLIENTVERSION=2.40.0&amp;Q_CLIENTTYPE=web&amp;Q_BRANDID=nlmenterprise" defer=""></script><script src="https://siteintercept.qualtrics.com/dxjsmodule/FeedbackButtonModule.js?Q_CLIENTVERSION=2.40.0&amp;Q_CLIENTTYPE=web&amp;Q_BRANDID=nlmenterprise" defer=""></script><style type="text/css">.QSIFeedbackButton div,.QSIFeedbackButton dl,.QSIFeedbackButton dt,.QSIFeedbackButton dd,.QSIFeedbackButton ul,.QSIFeedbackButton ol,.QSIFeedbackButton li,.QSIFeedbackButton h1,.QSIFeedbackButton h2,.QSIFeedbackButton h3,.QSIFeedbackButton h4,.QSIFeedbackButton h5,.QSIFeedbackButton h6,.QSIFeedbackButton span,.QSIFeedbackButton pre,.QSIFeedbackButton form,.QSIFeedbackButton fieldset,.QSIFeedbackButton textarea,.QSIFeedbackButton p,.QSIFeedbackButton blockquote,.QSIFeedbackButton tr,.QSIFeedbackButton th,.QSIFeedbackButton td{ margin: 0; padding: 0;background-color: transparent; border: 0; font-size: 12px; line-height: normal; vertical-align:baseline; box-shadow: none; }.QSIFeedbackButton img{ height: auto; width: auto; margin: 0; padding: 0 }.QSIFeedbackButton ul,.QSIFeedbackButton ol{ margin: 12px 0; padding-left: 40px; }.QSIFeedbackButton ul li{ list-style-type: disc; }.QSIFeedbackButton ol li{ list-style-type: decimal; }.QSIFeedbackButton .scrollable{ -webkit-overflow-scrolling: touch; }.QSIFeedbackButton table{ border-collapse: collapse; border-spacing: 0; }.QSIFeedbackButton table td{ padding: 2px; }.QSIFeedbackButton iframe{ max-height: none; }.QSIFeedbackButton *{ box-sizing: content-box; }</style><div class="QSIFeedbackButton" style="position: fixed; visibility: hidden; inset: 0px; display: flex; flex-direction: column; justify-content: flex-end; align-items: flex-start; margin: 0px; padding: 0px; z-index: 2000000000;"><button role="button" aria-label="Tell us what you think!" style="position: fixed; visibility: visible; cursor: pointer; border: none; background-color: transparent; padding: 0px; margin: 0px; bottom: 77px; right: -1px; width: 52px;" id="QSIFeedbackButton-btn"><img src="https://iad1.qualtrics.com/WRQualtricsSiteIntercept/Graphic.php?IM=IM_3xWqwNkIHc7cA0S" alt="Tell us what you think!" style="max-width: 110px; max-height: 110px; display: block;"></button></div></body>